Introduction {#s1}
============

Cardio-vascular diseases and sudden cardiac death (SCD) are together among the highest causes of mortality in the general population, and ventricular arrhythmias are identifiable in almost all cardiac diseases. The incidence of SCD and the poor outcome of sudden cardiac arrest make heart diseases a leading cause of mortality in young individuals ([@bib82]). Among frequent causes of SCD, numerous genetic mutations have been identified as responsible for arrhythmogenic cardiomyopathies, cardiac malformations or sympatho-vagal dysfunctions ([@bib9]; [@bib15]; [@bib39]). Congenital cardiac innervation defects or dysfunction are largely implicated in SCD and often involve molecules that are essential for the developmental guidance and axonal growth of cardiac sympathetic nerves, such as Sema3a and Ngf ([@bib22]; [@bib39]). Recently, two independent genome wide association studies based on abnormal cardiac conduction as an increased susceptibility to SCD have emphasized a restricted number of genes among which *Meis1* ([@bib93]; [@bib116]). Meis1 is a transcription factor of the TALE homeobox gene family, known to play important roles during embryonic development, cardiogenesis and postnatal cardiomyocytes turnover ([@bib85]; [@bib117]; [@bib72]).

The early steps of sympathetic neurons development have been extensively documented. During sympathetic neurons formation, a concerted cross-regulated transcriptional network induced by BMPs and involving among others the transcription factors Hand2, Ascl1, Phox2b and Gata3 initially instructs neural crest cells to a sympathetic fate and a noradrenergic phenotype by up-regulating the expressions of general neuronal markers and the monoamines biosynthesis enzymes tyrosine hydroxylase (TH) and dopamine-β-hydroxylase (DBH) ([@bib107]). Subsequently, connecting sympathetic neurons with their peripheral target relies on combined actions of locally secreted ligands of various families of trophic factors ([@bib42]; [@bib34]; [@bib35]). Artn, a growth factor of the Gdnf family of ligands, acting on GFRα3 and Ret, and the neurotrophin Ntf3 are initially involved in proximal axonal growth, and members of the endothelin family serve as vascular-derived guidance cues for sympathetic neurons ([@bib5]; [@bib33]; [@bib50]; [@bib62]; [@bib74]; [@bib77]), allowing sympathetic axons to reach the vicinity of target organs. At later stages, distal axonal growth and target-field innervation are under the control of retrograde Ntrk1/Ngf signaling for most organs including the heart ([@bib41]). Ngf is secreted in limiting amounts by target organs and binds the high affinity receptor Ntrk1 to induce its phosphorylation and internalization both by clathrin-dependent and independent mechanisms. Retrogradely transported Ngf/Ntrk1 is mediated by Rab5-positive endosomes. This signaling induces phosphorylation of CREB and allows the maintenance of Ntrk1 expression both of which are required to promote axonal growth and branching of sympathetic neurons within their peripheral target organs, and to protect them from naturally occurring cell death ([@bib20]; [@bib115]; [@bib103], [@bib102]; [@bib61]; [@bib70]; [@bib141]; [@bib62]; [@bib133]; [@bib44]; [@bib120]). Whereas part of the transcriptional program regulating the induction of Ntrk1 expression has been revealed in the peripheral nervous system (PNS) through analysis of the effects of *Klf7* inactivation ([@bib64]), the transcriptional regulation of molecules implicated in retrograde Ngf/Ntrk1 transport mechanisms in particular or endosomal transport in general are unknown.

We aimed in our study at investigating if Meis1 participates in neural aspects of cardiac regulation by intervening in the differentiation of sympathetic neurons and how *Meis1* mutations could mediate susceptibility for unexplained SCD.

In this work, we highlight that loss of *Meis1* function in early sympathetic neurons leads to an imbalanced sympatho-vagal regulation of cardiac functions in adult mice resulting in increased susceptibility to SCD. We further demonstrate that this imbalance results from neurodevelopmental defects leading to sympathetic neurons apoptosis and we position *Meis1* as novel actor in sympathetic neurons differentiation by its role in distal target-field innervation. Among the target genes regulated by Meis1, we evidenced a transcriptional regulation of proteins necessary for retrograde transport, endosomes formation, functioning and traffic. Accordingly, following specific inactivation of *Meis1* in peripheral neurons, the traffic of Rab5^+^ early endosomes is impaired and sympathetic target-field innervation is compromised.

Results {#s2}
=======

*Meis1* inactivation in the PNS compromises the sympatho-vagal regulation of cardiac function. {#s2-1}
----------------------------------------------------------------------------------------------

To examine the consequences of specific inactivation of *Meis1* in the mouse peripheral nervous system (PNS), the PLAT^CRE^ strain was crossed with the *Meis1^LoxP/LoxP^* strain ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). Immunochemistry and Western blot analysis showed a complete loss of *Meis1* in sympathetic neurons from E16.5 embryo and adult mutant mice ([Figure 1A](#fig1){ref-type="fig"}). When grown in a C57BL/6 genetic background, *PLAT^CRE^::Meis1^LoxP/LoxP^* mice carried *Meis1* alleles according to a Mendelian ratio but newborn pups died within the first days following birth. When grown in a mixed genetic background, 50% of the mutant mice survived beyond early neonatal stages and exhibited blepharoptosis ([Figure 1A](#fig1){ref-type="fig"}), a physiological sign of sympathetic neurons dysfunction. However, most mutants died prematurely and unpredictably before reaching adult stages ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). The premature death of *PLAT^CRE^::Meis1^LoxP/LoxP^* mice together with their drooping eyelids phenotype led us to hypothesize impairments of sympathetic functions and consequent SCD. Accordingly, we found that newborn and adult mutants exhibited a dramatic reduction in cardiac sympathetic innervation by TH^+^ fibers ([Figure 1A](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1F and G](#fig1s1){ref-type="fig"}). WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* adult mice were telemetrically monitored for ECG recordings and processed with Heart Rate Variability (HRV) analysis, a method allowing quantifying autonomic nervous system (ANS) activity on heart rate. Measurements of the mean PR, QRS and QTc intervals on sinus cycle during baseline showed no differences between groups ([Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}), excluding the participation of intrinsic cardiac ion channels mediating conduction or repolarization in this phenotype. However, mutant mice developed paroxysmal abnormal atrial and/or atrioventricular nodal conduction that led to spontaneous bradycardia or desynchronization, in which P waves were either progressively lengthened, absent, premature or retrograde ([Figure 1B](#fig1){ref-type="fig"}). These altered conductions were concomitant with a high occurrence of sinus arrest ([Figure 1E](#fig1){ref-type="fig"}) and a permanent bradycardia (overall increased mean RR interval), corroborated by an increased HRV parameter SDNN (a calculation of total heart beat-to-beat variability resulting from cardiac ANS activity) ([Figure 1C](#fig1){ref-type="fig"}). HRV analysis in the frequency domain (calculated by Fast Fourier transform applied on exclusively sinus successive RR intervals) confirmed a severe decrease in LF/HF ratio (a marker of sympatho-vagal activity) due to a drop in the LF band (a marker of sympathetic activity) in *PLAT^CRE^::Meis1^LoxP/LoxP^ vs* WT mice without affecting the HF component (a marker of parasympathetic activity), demonstrating that the sympathetic only but not the parasympathetic component is affected ([Figure 1C](#fig1){ref-type="fig"}). WT and mutant mice were challenged by i.p. injection of the sympatho-mimetic isoproterenol or by the muscarinic agonist carbamoylcholine chloride ([Figure 1D](#fig1){ref-type="fig"}). The increased and decreased RR intervals following carbamoylcholine chloride and isoproterenol injections respectively ([Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}) indicated that the cholinergic and β-adrenergic machineries within cardiomyocytes are functional in both animals groups. However, whereas isoproterenol induced-heart rate acceleration was rapidly and progressively counterbalanced by endogenous parasympathetic activation, carbamoylcholine chloride challenge caused a persistent and sustained bradycardia that was lethal for 3 out of 8 mutant mice, confirming the lack of endogenous sympathetic activity to counterbalance this effect. We further performed exercise tests on the treadmill ([Figure 1F](#fig1){ref-type="fig"}). Whereas a significant 45% decrease in the RR interval was recorded in WT mice during the effort (p\<0.01, n = 8), a non-significant and delayed 13% decrease in the RR interval was observed in *PLAT^CRE^::Meis1^LoxP/LoxP^* mice. In contrast to control WT mice, during the recuperation phase, 75% of *PLAT^CRE^::Meis1^LoxP/LoxP^* mice developed ventricular fibrillations followed by cardiac arrest that was occasionally cardio-converted as shown in [Figure 1F](#fig1){ref-type="fig"}.10.7554/eLife.11627.003Figure 1.Specific *Meis1* inactivation in the PNS results in sympatho-vagal deregulation of cardiac functions.(**A**) Immunochemistry for Meis1 and the transcription factor Phox2b on sections of SCGs from E16.5 WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* mice, and western blot analysis for Meis1 from adult stellate ganglia. Surviving adult mutants exhibited blepharoptosis (white dotted square). Immunostaining for TH^+^ sympathetic fibers in the heart of newborn WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* mice. VE = Ventricle, AR = Atrium. White arrows point at TH^+^ sympathetic fibers. Scale bar = 20 µm. (**B**) Example of an ECG trace recorded in an adult male *PLAT^CRE^::Meis1^LoxP/LoxP^* mouse. The black arrow indicates the start of a junctional bradycardia and the red asterisks mark abnormal P waves locations. Dotted black square delineates the power magnification of the ECG trace showed. (**C**) HRV analysis of the ECGs recordings of *PLAT^CRE^::Meis1^LoxP/LoxP^* and WT mice. Graphical representations of the mean RR interval, the standard deviation of all normal to normal beats (SDNN), the power of low frequency band (LF), the power of the high frequency band (HF) and the LF/HF ratio. (**D**) Time course of the mean RR interval during isoproterenol or carbamoylcholine chloride challenges in WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* mice. (**E**) Typical sinus arrest (SA) trace obtained in a *PLAT^CRE^::Meis1^LoxP/LoxP^* mouse and quantification of the mean number of sinus arrest per hour over a 12 hr ECG recording in *PLAT^CRE^::Meis1^LoxP/LoxP^ vs* WT mice. (**F**) Mean RR interval after treadmill exercise. Typical ECG trace during the recuperation period following treadmill exercise. Data are represented as mean +/- s.e.m. n = 8 in each group; \*p\<0.05, \*\*\*p\<0.001. See also [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} and [2](#fig1s2){ref-type="fig"} , [Figure 1---source data 1.](#SD1-data){ref-type="supplementary-material"}**DOI:** [http://dx.doi.org/10.7554/eLife.11627.003](10.7554/eLife.11627.003)10.7554/eLife.11627.004Figure 1---source data 1.Morphologic and left ventricular function parameters assessed by Doppler echocardiography in WT and **PLAT^CRE^::Meis1^LoxP/LoxP^** mice.HR, heart rate; AWTd, anterior wall thickness during diastole; AWTs, anterior wall thickness during systole; LVIDd, left ventricular internal diameter during diastole; LVIDs, left ventricular internal diameter during systole; PWTd, posterior wall thickness during diastole; PWTs, posterior wall thickness during systole; EF, ejection fraction; FS, fractional shortening; FAC, fractional area change; AoVTI, aortic velocity time integral; E, mitral inflow early filling velocity; A, mitral inflow late filling velocity. Data are represented as mean ± SD. Abbreviations: **HR: [H]{.ul}**eart **[R]{.ul}**ate; **AWTd: [A]{.ul}**nterior **[W]{.ul}**all **[T]{.ul}**hickness during **[d]{.ul}**iastole; **AWTs: [A]{.ul}**nterior **[W]{.ul}**all **[T]{.ul}**hickness during **[s]{.ul}**ystole; **LVIDd: [L]{.ul}**eft **[V]{.ul}**entricular **[I]{.ul}**nternal **[D]{.ul}**iameter during **[d]{.ul}**iastole; **LVIDs: [L]{.ul}**eft **[V]{.ul}**entricular **[I]{.ul}**nternal **[D]{.ul}**iameter during **[s]{.ul}**ystole; **PWTd: [P]{.ul}**osterior **[W]{.ul}**all **[T]{.ul}**hickness during **[d]{.ul}**iastole; **PWTs: [P]{.ul}**osterior **[W]{.ul}**all **[T]{.ul}**hickness during **[s]{.ul}**ystole; **EF** (%) M-mode: **[E]{.ul}**jection **[F]{.ul}**raction; **FS** (%) M-mode: **[F]{.ul}**ractional **[S]{.ul}**hortening; **Ao VTI: [Ao]{.ul}**rtic flow **[V]{.ul}**elocity **[T]{.ul}**ime **[I]{.ul}**ntegral; **E wave**: Mitral inflow early filling velocity (passive inflow); **A wave**: Mitral inflow late filling velocity (active inflow); **E/A**: Ratio **[E]{.ul}** wave / **[A]{.ul}** wave **FAC** (%): Fractional area; **EF** (%) B-mode: **[E]{.ul}**jection **[F]{.ul}**raction measured on B-mode.**DOI:** [http://dx.doi.org/10.7554/eLife.11627.004](10.7554/eLife.11627.004)10.7554/eLife.11627.005Figure 1---figure supplement 1.Sympatho-vagal deregulation of cardiac functions following *Meis1* inactivation in the PNS.(**A**) Targeting vector used for the generation of the Meis1 conditional knockout mouse strain (*Meis1^LoxP/LoxP^*). The exon 8 of the gene encoding the beginning of the homeodomain has been flanked with LoxP sites. (**B**) Kaplan-Meier survival curve showing the premature death of *PLAT^CRE^::Meis1^LoxP/LoxP^* mice (in red) compared to WT mice (in black). (**C**) Measure of the PR, QRS and QTc intervals on a 24 hr ECG telemetric recording showed no statistically difference between groups, indicating that *Meis1* invalidation in the PNS does not affect the intrinsic cardiac conduction properties. (**D**) Table recapitulating the minimum RR (RR~min~), corresponding to the maximal effect of isoproterenol on heart rate and the time to lose half of the effect (T~1/2~RRmin), the maximum RR interval (RR~max~), corresponding to the maximal effect of carbamoylcholine chloride and the duration to lose half of the effect (T~1/2~RR~max~) in WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* mice. Data are represented as mean +/- s.e.m., n = 8 in all experiments. (**E**) Histologic section of E14.5 WT, *PLAT^CRE^::Meis1^LoxP/LoxP^* and *Wnt1^CRE^::Meis1^LoxP/LoxP^* hearts embryos. Whereas the cardiac septum was identical to that of WT in 3/3 analyzed *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos, we observed a defect in the cardiac septum of 1/1 *Wnt1^CRE^::Meis1^LoxP/LoxP^* embryo. Scale bar = 500 µm. (**F**) Quantification of the density of TH^+^ sympathetic fibers on sections of the heart in *PLAT^CRE^::Meis1^LoxP/LoxP^* and WT adult mice. (**G**) Representative images showing that the remaining fibers in *PLAT^CRE^::Meis1^LoxP/LoxP^* are thinner than in WT mice. Data are represented as mean +/- s.e.m. n = 2. Scale bars = 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.11627.005](10.7554/eLife.11627.005)10.7554/eLife.11627.006Figure 1---figure supplement 2.Cardiac echography analysis revealed no difference following *Meis1* inactivation.(**A**) Representative B-mode images of heart parasternal long axis view. (**B**) Representative B-mode images of heart short axis view. (**C**) Representative M-mode images of heart short axis view at the level of papillary muscle. (**D**) Representative mitral inflow velocity from the apical four view chamber. Evaluations of left ventricular morphology and function by Doppler echocardiography showed no difference between WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* mice.**DOI:** [http://dx.doi.org/10.7554/eLife.11627.006](10.7554/eLife.11627.006)

Because *Meis1* inactivation has been linked to cardiac septum defect ([@bib117]), a structure derived partly from neural crest cells ([@bib53]), and to exclude the possible participation of such defects in the cardiac phenotype we observed, heart sections from E14.5 and E16.5 WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* were analyzed. In 3/3 E14.5 and 5/5 E16.5 mutant embryos analyzed, we never observed any defect in cardiac septum closure. However, in 1/1 *Wnt1^CRE^::Meis1^LoxP/LoxP^*, a CRE driver commonly used to recombine in cardiac neural crest derivatives ([@bib16]), the cardiac septum was not fully closed ([Figure 1---figure supplement 1E](#fig1s1){ref-type="fig"}).

In addition, we performed transthoracic-echocardiography measurements in the parasternal long and short axis views ([Figure 1---figure supplement 2,A and B](#fig1s2){ref-type="fig"} respectively) to characterize heart structure, contractile function and morphology. Both views did not revealed any defect in the septum of *PLAT^CRE^::Meis1^LoxP/LoxP^* mice and the ejection fraction (EF), which is used as the conventional contractile function index, was not different from WT mice ([Figure 1---figure supplement 2C](#fig1s2){ref-type="fig"} and [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). In addition, measuring systolic performance tracing all along endocardial end-diastolic and end-systolic borders (EF B-mode and FAC; [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}) excluded a left ventricular abnormal regional remodeling. Finally, heart diastolic performance assessed by measuring left ventricle filling waves in standard 4 cavities view. ([Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"} and E/A ratio in [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}) did not show any difference. Thus, *PLAT^CRE^::Meis1^LoxP/LoxP^* mice present no cardiac malformations and exhibit normal hemodynamic parameters suggesting that the outflow tract is unaffected.

Altogether, these explorations revealed that *PLAT^CRE^::Meis1^LoxP/LoxP^* mice present profound alterations in the sympatho-vagal regulation of cardiac functions, affecting specifically the sympathetic component whereas the parasympathetic component is unaffected. The high occurrence of sinus arrest together with spontaneous blocks of conduction, chronotropic incompetence and episodes of ventricular fibrillation following exercise clearly point to a high increased risk for SCD in adult *PLAT^CRE^::Meis1^LoxP/LoxP^* mice dependent on altered sympatho-vagal control of heart rhythm and independent of cardiac malformations. Together with the reduced sympathetic innervation of cardiac tissue, these results led us to investigate in depth the role of Meis1 function in sympathetic neurons.

The onset of Meis1 expression is compatible with a function in target-field innervation but not early sympathetic specification. {#s2-2}
--------------------------------------------------------------------------------------------------------------------------------

To decipher Meis1 function in sympathetic neurons, we first examined its expression during mouse superior cervical ganglia (SCG) formation. By in situ hybridization (ISH), we compared its mRNA expression to that of well-established early markers for sympathetic neurons and their precursors. We found that at E11.5, whereas noradrenergic differentiation has already been initiated as seen by the onset of Gata3, Phox2b and TH expressions, sympathetic neurons did not express Meis1 or Klf7 transcripts ([Figure 2A](#fig2){ref-type="fig"}). Meis1 mRNA expression was first faintly detected at E12.5, after the onset of noradrenergic specification in most neurons, together with Ntrk1, Klf7, and Ret, the receptor for the Gdnf family of ligands ([Figure 2B](#fig2){ref-type="fig"}). At E14.5, all sympathetic neurons, including neurons in the stellate and the ganglionic chain, showed a strong Meis1 mRNA expression ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). The other members of the Meis family, Meis2 and Meis3, were never expressed by these neurons at any of the analyzed stages ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). At E16.5, Meis1 mRNA co localized indifferently with DBH or with the presumptive marker for cholinergic sympathetic neurons Ret ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). The relatively late expression of Meis1 after that of Gata3, Phox2b and TH strongly suggests that Meis1 is not involved in early sympathetic neurons specification. Immunochemistry confirmed the complete loss of Meis1 in sympathetic neurons from 14.5 and E16.5 *PLAT^CRE^::Meis1^LoxP/LoxP^* mutant embryos, ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). In E14.5 mutant embryos, the SCGs were normally formed and positioned, indicating that the formation, survival and migration of neural crest cells, the precursors of sympathetic neurons, were unaffected. At this stage, *Meis1* loss of function did not affect the expression of Gata3, Hand2, Phox2b and TH ([Figure 2C](#fig2){ref-type="fig"}). Collectively, these results demonstrate that Meis1 function is dissociated from early noradrenergic specification and early diversification of sympathetic neurons. Conversely, the simultaneous temporal expression of Meis1 with Ntrk1 and Klf7 led us to hypothesize that Meis1 is involved in later aspects of sympathetic neurons development during the period of target-field innervation and/or survival.10.7554/eLife.11627.007Figure 2.Meis1 expression in sympathetic neurons is incompatible with early sympathetic specification but coincides with target-field innervation onset.(**A**) ISH for Meis1, Gata3 and Klf7, and immunochemistry for Phox2b and TH in WT E11.5 embryonic SCGs. (**B**) ISH for Meis1, Hand2, Gata3 and Klf7 and immunochemistry for Phox2b, TH, Ntrk1 and Ret in WT E12.5 embryonic SCGs. White arrows point at Ntrk1 or Ret neurons. (**C**) ISH for Gata3 and Hand2 and immunochemistry for Phox2b and TH on WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* E14.5 embryonic SCGs. White and black dotted lines delineate the SCGs. Scale bar = 20 µm. See also [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.11627.007](10.7554/eLife.11627.007)10.7554/eLife.11627.008Figure 2---figure supplement 1.*Meis1* is the only member of the *Meis* family to be expressed by embryonic sympathetic neurons and is indifferently expressed by noradrenergic and cholinergic sympathetic neurons.(**A**) In situ hybridization (ISH) for Meis1, Meis2 and Meis3 on E11.5, E13.5 and E14.5 WT embryos showed that Meis1 is the only member of the family to be expressed in sympathetic ganglia. Black dashed lines encircles the SCGs. (**B**) Double ISH for Meis1 (pseudo color in red) with Dopamine β-Hydroxylase (DBH, pseudo color in green) or with Ret (pseudo color in red) indicated that both major subpopulations (noradrenergic and presumptive cholinergic) of sympathetic neurons expressed Meis1 at E16.5. White arrowheads point at double positive neurons. White dotted lines encircle the SCGs. (**C**) Immunochemistry for Phox2b and Meis1 on SCGs from E14.5 and E16.5 WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos confirmed the loss of Meis1 protein at these stages. Scale bars = 20 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.11627.008](10.7554/eLife.11627.008)

*Meis1* deficient sympathetic neurons progressively die by apoptosis. {#s2-3}
---------------------------------------------------------------------

To test this hypothesis, we first investigated sympathetic neurons survival and followed the embryonic development of the SCGs in E14.5, E16.5 and E18.5 WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos. In WT embryos, there was a 1.8 fold increase in the volume of the SCGs between E14.5 and E16.5, and a 3.3 fold increase between E14.5 and E18.5. In *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos, we measured a slight reduction of 25% and a dramatic reduction of 60% in the volume of the ganglia at E16.5 and E18.5 respectively ([Figure 3A and B](#fig3){ref-type="fig"}). We then investigated if the decreased volume of the SCGs in mutant embryos was due to neuronal apoptosis. We found an increase of Casp3^+^ apoptotic sympathetic neurons in *PLAT^CRE^::Meis1^LoxP/LoxP^* compared to WT at both E14.5 and E16.5. In E14.5 and E16.5 WT embryos, we counted 1.8 ± 0.4% and 1.3 ± 0.6% of Casp3^+^ neurons per section respectively, whereas in *PLAT^CRE^::Meis1^LoxP/LoxP^*, we found 5.6 ± 1.1% and 7.6 ± 1.1% of Casp3^+^ sympathetic neurons per section at E14.5 and E16.5 respectively ([Figure 3C](#fig3){ref-type="fig"}). To investigate if glial defects could contribute to the decreased ganglia volume, we conducted immunochemistry for Sox2 and ISH for Sox10, two well-described markers of peripheral glial cells and neural precursors. As expected, Sox2 never colocalized with the neuronal marker Phox2b ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}), and there was no change in the number of Sox2^+^ or Sox10^+^ glial progenitor cells at E16.5 nor in the number of Sox2^+^ cells at E14.5 ([Figure 3---figure supplement 1A, C and D](#fig3s1){ref-type="fig"}). Casp3^+^ cells never coexpressed Sox2 but largely colocalized with TH ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). To further confirm that the neuronal loss was due to apoptosis, we generated triple *PLAT^CRE^::Meis1^LoxP/LoxP^::Bax^-/-^*mutant embryos. As expected, we found that inactivating the pro-apoptotic gene *Bax* in *PLAT^CRE^::Meis1^LoxP/LoxP^* mice rescued sympathetic neurons from apoptosis and there was no significant difference in the number of Phox2b^+^ neurons of the SCGs of newborn P0 *Bax^-/-^vs PLAT^CRE^::Meis1^LoxP/LoxP^::Bax^-/-^* mice ([Figure 3E](#fig3){ref-type="fig"}). Of note, Phox2b expression was not altered in *Meis1* deficient sympathetic neurons rescued from apoptosis at this stage, further confirming that Meis1 functions are independent of noradrenergic specification. Finally, because early sympathetic neurons continue to divide up to perinatal stages, and to exclude the contribution of this mechanism to the decrease in ganglia size, we evaluated their proliferation and demonstrated that the proliferative rates were not affected at any of the analyzed stages in *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}).10.7554/eLife.11627.009Figure 3.Exacerbated neuronal apoptosis in *Meis1* mutant sympathetic neurons.(**A**) ISH for Gata3 on SCGs of *PLAT^CRE^::Meis1^LoxP/LoxP^* and WT embryos at E14.5, 16.5 and E18.5. (**B**) Quantification of the volume of the SCGs in WT *vs PLAT^CRE^::Meis1^LoxP/LoxP^* mice at E14.5, E16.5 and E18.5. (**C**) Representative images of the SCGs visualized by immunochemistry for activated Caspase-3 (Casp3) and TH at E16.5 in WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* mice. Arrows point at Casp3^+^/TH^+^ neurons. (**D**) Quantification of the average number of Casp3^+^/TH^+^ neurons per section in the SCGs of *PLAT^CRE^::Meis1^LoxP/LoxP^* and WT embryos at E14.5 and E16.5. (**E**) Immunochemistry for Phox2b and TH on SCGs of P0 WT, *Bax*^-/-^, *PLAT^CRE^::Meis1^LoxP/LoxP^* and *PLAT^CRE^::Meis1^LoxP/LoxP^::Bax^-/-^* newborn pups, and quantification of the number of Phox2b^+^ neurons per SCG in P0 WT, *Bax^-/-^, PLAT^CRE^::Meis1^LoxP/LoxP^* and *Bax^-/-^::PLAT^CRE^::Meis1^LoxP/LoxP^* mice. Data are represented as mean +/- s.e.m. n = 3; \*p≤0.05; \*\*p≤0.01; \*\*\*p≤0.005. Scale bar = 20 µm. See also [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} and [2](#fig3s2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.11627.009](10.7554/eLife.11627.009)10.7554/eLife.11627.010Figure 3---figure supplement 1.Survival of glial progenitor cells is not affected following *Meis1* inactivation.(**A**) ISH for Sox10 and immunochemistry for Sox2 and Casp3 on E14.5 and E16.5 SCGs from WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos. White arrows point at Casp3^+^ cells. (**B**) Immunochemistry for Sox2 and Phox2b on E14.5 SCGs showed that their expressions are mutually exclusive. Immunochemistry for Sox2 or TH with Casp3 showed that Casp3 immunoreactivity was present in TH^+^ neurons but never in Sox2^+^ glial progenitor cells. (**C**) Quantification of the number of Sox10^+^ cells in E16.5 WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* SCGs. (**D**) Quantification of the number of Sox2^+^ cells in E14.5 and E16.5 WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* SCGs. Data are represented as mean +/- s.e.m. n = 3; Scale bars = 20 µm in A and B.**DOI:** [http://dx.doi.org/10.7554/eLife.11627.010](10.7554/eLife.11627.010)10.7554/eLife.11627.011Figure 3---figure supplement 2.*Meis1* inactivation does not affect early proliferation of sympathetic neurons.(**A**) Pregnant mice were injected with 0.7 mg 5-ethynyl-2´-deoxyuridine (EdU) at 14 and 16 days post-coitum. 3 hr following injection, pregnant mice were sacrificed and embryos were dissected, fixed in PFA and crysosectionned. Chemical revelation of EdU incorporation combined with immunochemistry for Phox2b on E16.5 SCGs from WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos showed no difference between the two genotypes. (**B**) Quantification of the number of Phox2b^+^ neurons that incorporated EdU per section in SCGs from E14.5 and E16.5 WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos showed that about 18 to 22% of sympathetic neurons divided within the two last hours. No significant difference was observed between WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos. Data are represented as mean +/- s.e.m. n = 3. Scale bar = 20 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.11627.011](10.7554/eLife.11627.011)

In summary, the loss of SCG neurons in *PLAT^CRE^::Meis1^LoxP/LoxP^* mice occurs in two phases, an early phase (E14.5 -- E16.5) with a moderate increase of neuronal apoptosis and a small variation in the volume of the SCGs, a later phase (E16.5 --18.5) with a dramatic reduction in the volume of the SCGs.

Distal target-field innervation but not proximal axonal growth is impaired in *Meis1*-inactivated sympathetic neurons. {#s2-4}
----------------------------------------------------------------------------------------------------------------------

We next investigated whether the progressive neuronal loss was a consequence of impaired proximal and/or distal axonal growth. Proximal axonal growth was unaffected as seen by the presence of sympathetic nerves exiting the SCGs in both E14.5 and E16.5 WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos ([Figure 4A](#fig4){ref-type="fig"}). To test whether distal target-field innervation was affected, we investigated TH immunoreactivity in peripheral organs at E16.5 to visualize sympathetic innervation within target organs. Whereas the density of PGP9.5^+^/TH^-^ fibers representing non-sympathetic peripheral innervation was similar in WT and mutant embryos, we found a dramatic decrease in PGP9.5^+^/TH^+^ sympathetic fibers in the heart of *PLAT^CRE^::Meis1^LoxP/LoxP^* compared to WT embryos ([Figure 4B and C](#fig4){ref-type="fig"}). Measurements revealed a 77 ± 12% reduction in TH^+^ sympathetic innervation density of the heart in *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos compared to WT ([Figure 4C](#fig4){ref-type="fig"}). Similarly, we measured a marked reduction in TH^+^ sympathetic innervation densities of the salivary glands, the vomeronasal organ, the tongue and the trachea of mutant embryos ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). In addition, preventing apoptosis of sympathetic neurons lacking *Meis1* by *Bax* mutation did not rescue the defects in sympathetic cardiac innervation at P0 ([Figure 4D](#fig4){ref-type="fig"}). These results demonstrated that in the absence of Meis1, sympathetic target-field innervation, but not proximal axonal growth, is compromised.10.7554/eLife.11627.012Figure 4.Lack of terminal sympathetic target-field innervation in *Meis1* mutant embryos.(**A**) Immunochemistry for TH on SCGs from E14.5 and E16.5 WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos showing that proximal axonal growth of sympathetic neurons is not affected. Sy Nerve = sympathetic nerve. (**B**) Visualization of TH^+^ sympathetic fibers and others PGP9.5^+^/TH^-^ peripheral neurons projections in the heart of *PLAT^CRE^::Meis1^LoxP/LoxP^* and WT embryos at E16.5. Arrows point at TH^+^ sympathetic fibers and arrowheads point at PGP9.5^+^/TH^-^ nerves. (**C**) Quantification of the density of TH^+^/PGP9.5^+^ sympathetic and TH^-^/PGP9.5^+^ sensory fibers on heart sections of *PLAT^CRE^::Meis1^LoxP/LoxP^* and WT embryos at E16.5. (**D**) Representative images and quantification of TH^+^ sympathetic fibers in the heart of *Bax^-/-^* and *PLAT^CRE^::Meis1^LoxP/LoxP^::Bax^-/-^* newborn pups. Data are represented as mean +/- s.e.m. n = 3; \*\*p≤0.01. Scale bar = 20 µm. See also [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.11627.012](10.7554/eLife.11627.012)10.7554/eLife.11627.013Figure 4---figure supplement 1.Sympathetic target-field innervation of peripheral organs is compromised following *Meis1* loss of function.(**A** and **B**) Visualization of TH^+^ sympathetic fibers (in red) and others PGP9.5^+^/TH^-^ peripheral nervous projections (in green) by immunochemistry in the salivary glands (**A**) and the trachea (**B**) of *PLAT^CRE^::Meis1^LoxP/LoxP^* and WT embryos at E16.5. Only the TH^+^ sympathetic innervation is affected in the mutant. Arrows point at TH^+^ sympathetic fibers and arrowheads point at PGP9.5^+^/TH^-^ nerves. (**C**) Visualization by immunochemistry of TH^+^ sympathetic fibers (in red) in the tongue and the vomeronasal organ of *PLAT^CRE^::Meis1^LoxP/LoxP^* and WT embryos at E16.5. Arrows point at TH^+^ sympathetic fibers. (**D**) Quantification of the density of TH^+^ sympathetic fibers on sections of the salivary glands, the vomeronasal organ, the tongue and the trachea in *PLAT^CRE^::Meis1^LoxP/LoxP^* and WT embryos at E16.5 revealed that SCG neurons failed to establish contact with their peripheral targets during embryogenesis. Data are represented as mean +/- s.e.m. n = 3; \*\* p≤0.01; \*\*\* p≤0.005. Scale bars = 20 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.11627.013](10.7554/eLife.11627.013)

Loss of target-field innervation signaling pathways in *Meis1*-inactivated sympathetic neurons. {#s2-5}
-----------------------------------------------------------------------------------------------

According to the neurotrophic hypothesis, most sympathetic neurons depend on retrograde Ngf/Ntrk1 signaling for target-field innervation and survival. Ngf/Ntrk1 retrograde signaling is necessary for the maintenance of Ntrk1 expression and accumulation of phosphorylated CREB (pCREB) within neuronal nuclei ([@bib27]; [@bib103]). Thus, defects in retrograde Ngf/Ntrk1 signaling would result in altered target-field innervation without proximal growth defects and a massive neuronal apoptosis concomitant to naturally occurring cell-death, a phenotype that resembles the phenotype we observed during the second phase of neuronal loss in *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos. To establish a possible link between Meis1 and Ngf/Ntrk1 signaling, we performed ISH and immunochemistry for Ntrk1. We found a reduction of 73 ± 11% and of 73 ± 6% in Ntrk1 ISH and immunofluorescence signal intensities respectively in the SCGs of E16.5 *PLAT^CRE^::Meis1^LoxP/LoxP^* compared to WT ([Figure 5A--D](#fig5){ref-type="fig"}). In contrast, no change in Ntrk1 mRNA levels was observed at E14.5 ([Figure 5A](#fig5){ref-type="fig"}). The expression levels of the other receptors for the neurotrophins family Ntrk2, Ntrk3 and Ngfr were identical in E16.5 WT and mutant SCGs ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). Together these results show that *Meis1* is necessary for the maintenance of Ntrk1 expression but not its induction. In addition, we conducted ISH for Klf7 and found a 49 ± 3% reduction in Klf7 mRNA expression in E16.5 sympathetic neurons of mutant embryos ([Figure 5E and F](#fig5){ref-type="fig"}). To confirm that apoptosis was not responsible for the decrease in Klf7 and Ntrk1 expressions, similar staining were conducted on sections from *PLAT^CRE^::Meis1^LoxP/LoxP^::Bax^-/-^* and *Bax^-/-^* P0 newborn mice, and we found a comparable decrease of 91 ± 4% in Ntrk1 expression ([Figure 5G and H](#fig5){ref-type="fig"}). Klf7 expression also was not maintained in *PLAT^CRE^::Meis1^LoxP/LoxP^::Bax^-/-^* newborn mice ([Figure 5E](#fig5){ref-type="fig"}). As a readout of retrograde Ngf/Ntrk1 signaling, we investigated pCREB immunoreactivity in sympathetic neurons nuclei. At E14.5, most of the mutant neurons failed to express pCREB ([Figure 5I](#fig5){ref-type="fig"}) and by E16.5, pCREB signal intensity was largely reduced in all the nuclei of mutant neurons compared to WT ([Figure 5J](#fig5){ref-type="fig"}), indicating that downstream signaling of Ngf/Ntrk1 retrograde signaling is perturbed following *Meis1* inactivation. A possible explanation of these defects could be that Meis1 itself is a downstream effector of Ngf/Ntrk1 retrograde signaling. To test this hypothesis, we performed immunochemistry for Meis1 on SCGs from E17.5 Ngf^-/-^ embryos. We found that Meis1 expression was unchanged when *Ngf* is inactivated ([Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}), indicating that it is not a downstream effector of Ngf/Ntrk1 signaling.10.7554/eLife.11627.014Figure 5.Target-field innervation signaling pathways in *Meis1*-inactivated sympathetic neurons.(**A**) ISH for the neurotrophins high affinity receptor Ntrk1 in E14.5 and E16.5 WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* SCGs. (**B**) Quantification of Ntrk1 ISH signal intensity in E16.5 WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* SCGs. (**C**) Immunochemistry for TH and Ntrk1 on E16.5 WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos. White dotted lines encircle the SCGs. (**D**) Quantification of the intensity of immuno-fluorescence for Ntrk1 in the SCGs of E16.5 WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos. (**E**) Representative images of ISH for Klf7 on SCGs of E16.5 WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos and on SCGs of P0 *Bax^-/-^* and *PLAT^CRE^::Bax^-/-^::Meis1^LoxP/LoxP^* mice. (**F**) Quantification of Klf7 ISH signal intensity in SCGs of E16.5 WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos. (**G**) Immunochemistry for TH and Ntrk1 on P0 *Bax^-/-^* and *PLAT^CRE^::Meis1^LoxP/LoxP^::Bax^-/-^* mice. (**H**) Quantification of the intensity of Ntrk1 immuno-fluorescence in the SCGs of P0 *Bax^-/-^* and *PLAT^CRE^::Meis1^LoxP/LoxP^::Bax^-/-^* mice. (**I**) Immunochemistry for pCREB and TH on E14.5 SCGs from WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos and quantification of the number of pCREB^+^ nuclei. (**J**) Immunochemistry for pCREB and TH on E16.5 SCGs from WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos and quantification of pCREB signal intensity in neuronal nuclei. Data are represented as mean +/- s.e.m. n = 3; \*p≤0.05; \*\*p≤0.01. Scale bar = 20 µm. See also [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} .**DOI:** [http://dx.doi.org/10.7554/eLife.11627.014](10.7554/eLife.11627.014)10.7554/eLife.11627.015Figure 5---figure supplement 1.*Meis1* loss of function does not interfere with the expression of other neurotrophins receptors than Ntrk1 and its expression is not dependent on Ngf/Ntrk1 signaling.ISH for Ntrk2 and Ntrk3, the high-affinity receptors for Ntf2 and Ntf3 respectively and for Ngfr, the low affinity receptor for all members of the neurotrophins family on WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* SCGs in E16.5. Whereas Ntrk3 and Ngfr mRNAs are expressed by sympathetic neurons at this stage, Ntrk2 is not detected. No variation in the expression of Ntrk3 or Ngfr mRNAs could be detected in *PLAT^CRE^::Meis1^LoxP/LoxP^ vs* WT embryos. Dashed black lines delineate the SCGs. (**B**) Immunochemistry for Meis1 on SCGs from E17.5 WT and *Ngf^-/-^* embryos showed that Meis1 expression does not depend on Ngf/Ntrk1 signaling. Scale bar = 20 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.11627.015](10.7554/eLife.11627.015)

All together, these results demonstrate that Ngf/Ntrk1 retrograde signaling is altered following *Meis1* inactivation. The decreased expression of Ntrk1 at E16.5 but not E14.5 suggests that during the early and late phases of cell loss in *Meis1* mutants, different signaling pathways are affected. In addition, whereas the rescue of *Meis1* inactivated neurons in a *Bax* null-context support the involvement of Ngf/Ntrk1 retrograde signaling in the late phase of neuronal apoptosis, the loss of innervation in the trachea clearly indicates that target-derived Ngf is not responsible alone, and that a more general mechanism is affected.

Impaired early endosome formation and traffic in *Meis1* inactivated neurons. {#s2-6}
-----------------------------------------------------------------------------

One hypothesis is that Meis1 controls the expression of effector genes that are functionally related to retrograde vesicular transport. Because Meis1 target genes in the nervous system are largely unidentified and to identify such effector genes, we performed a ChIP-seq analysis on SCGs of E16.5 WT embryos. High throughput sequencing identified putative regulatory regions near 309 potential target genes ([Figure 6---source data 1](#SD2-data){ref-type="supplementary-material"}). Bibliographical analyses revealed that about 34% of these genes are involved in target-field innervation and synapse function and/or architecture or both ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). We also found that many of the Meis1 potential target genes have been documented to participate in heart functions or pathologies ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"} and C and [Figure 6---source data 2](#SD3-data){ref-type="supplementary-material"}). Strikingly, a large number of the identified genes (65/309) were involved in vesicles formation, traffic and fusion or the regulation of exocytosis and/or endocytosis ([Figure 6---source data 3](#SD4-data){ref-type="supplementary-material"}). To see if such genes were transcriptionally regulated by Meis1, we selected a number of them for deeper analysis by ISH in WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos. We found that the expression of synaptotagmin1 (Syt1) mRNA was totally lost in E14.5 and E16.5 *Meis1* mutants embryos ([Figure 6A](#fig6){ref-type="fig"}). Similarly, the expressions of Lunapark (Lnp), Dystonin/Bpag1 (Dst), Neurobeachin (Nbea) and Adam19 were strongly reduced in E16.5 mutant embryos compared to WT ([Figure 6---figure supplement 1D](#fig6s1){ref-type="fig"}). Because endocytosis and retrograde transport-mediated survival and distal axonal growth are hallmarks of embryonic peripheral neurons and because Syt1 and Dst physically interact with clathrin, we investigated whether such processes were altered following *Meis1* loss of function. Visualizing clathrin coated vesicles by immunochemistry in E16.5 *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos revealed a dramatic decrease in clathrin-positive structures in the sympathetic axons innervating the heart, as well as in the cell bodies of sympathetic neurons ([Figure 6B,C](#fig6){ref-type="fig"}), suggesting perturbation in the traffic of endosomal cargoes.10.7554/eLife.11627.016Figure 6.Meis1 target genes encode proteins necessary for early endosomes formation.(**A**) ISH for Syt1 on SCGs of E14.5 and E16.5 WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos. (**B**) Immunochemistry for clathrin and TH on SCGs of E16.5 WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos. (**C**) Representative images and quantification of immunochemistry for clathrin and TH on the sympathetic nerves within the heart of E16.5 WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos. White arrowheads point at clathrin-coated pits and cargoes. (**D**) Immunochemistry for clathrin, TH, Syp1 and Rab5 and overexpression of a Rab5-GFP construct in cultured explants of SCGs from WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos. (**E**) Quantification of the numbers of Rab5, Rab5-GFP and clathrin^+^ cargoes in cultured explants of SCGs. Dotted lines encircle the SCGs. Scale bar = 20 µm in A, 10 µm in B and 5 µm in **C** and **D**. Data are represented as mean +/- s.e.m; n = 3; \*p≤0.05; \*\*\* p≤0.005. See also [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"} and [2](#fig6s2){ref-type="fig"}, and [Figure 6---source data 1](#SD2-data){ref-type="supplementary-material"}--[3](#SD4-data){ref-type="supplementary-material"} .**DOI:** [http://dx.doi.org/10.7554/eLife.11627.016](10.7554/eLife.11627.016)10.7554/eLife.11627.017Figure 6---source data 1.Meis1 target genes in embryonic sympathetic neurons.To identify Meis1 target genes, a ChIP-seq assay was conducted on E16.5 WT SCGs. The table includes the precipitated sequence ID (column A), the chromosome where the precipitated sequences match (column B), the start (column C) and the end (column D) of the precipitated sequences, the strand that the precipitated sequences recognize (column E), the name of the gene located within the 20kb of the precipitated sequence (column F), the gene accession number (column G), the strand where the 5'--3' genes is located (column H) and the fold enrichment *vs* control experiment (column I).**DOI:** [http://dx.doi.org/10.7554/eLife.11627.017](10.7554/eLife.11627.017)10.7554/eLife.11627.018Figure 6---source data 2.Bibliographical-based classification of Meis1 potential target genes.The table indicates the precipitated sequence ID (column A) and the chromosome where the precipitated sequences match (column B). Bibliographical search for each identified Mei1 potential target genes revealed a strong enrichment in genes involved in synapse formation, function and architecture (column C), in target-field innervation (column D) and/or cardiac functions and/or pathologies (column E).**DOI:** [http://dx.doi.org/10.7554/eLife.11627.018](10.7554/eLife.11627.018)10.7554/eLife.11627.019Figure 6---source data 3.Bibliographical classification of Meis1 potential target genes according to their function in endocytosis, exocytosis and vesicles transport.The table indicates the genes names with one major reference corresponding to their implication in synaptic machinery (column 1), their ability to bind the clathrin and/or the dynein complexes (column 2), their involvement in cargoes traffic (column 3), in microtubule-associated axonal growth (column 4), in the regulation of endocytosis (column 5) and others genes indirectly implicated in these functions (column 6). Importantly, because of their wide expression in different vesicles types, many of these genes such as Lnp, Syt1, Htt, Nav1 or Stab2 can be classified in more than one column. Genes highlighted in yellow were also identified by Wilson et al. ([@bib139]).**DOI:** [http://dx.doi.org/10.7554/eLife.11627.019](10.7554/eLife.11627.019)10.7554/eLife.11627.020Figure 6---figure supplement 1.Bibliographical classification of Meis1 potential target genes.(**A**) Diagram representing, among all identified Meis1 potential target genes, the percentage of genes with known functions in synapse machinery and target-field innervation. A significant proportion of these genes participate in both functions. (**B**) Diagram representing similarly the percentage of genes involved in target-field innervation, synaptogenesis and cardiac functions or pathologies with part of them involved in several of these processes. (**C**) Diagram showing, among selected target genes with known functions in synapse, target-field innervation and heart physiology and/or pathophysiology, the percentage of genes with function in both or all processes. Numbers in bracket indicate the absolute number of genes. (**D**) ISH for some of the Meis1 target genes identified by ChIP-seq and involved in cargoes formation, fusion or trafficking including Dst, Lnp, Adam19 and Nbea on SCGs of E16.5 WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos illustrating the deregulation of their mRNAs expressions in the mutants. Dotted lines encircle the SCGs. Scale bars = 20 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.11627.020](10.7554/eLife.11627.020)10.7554/eLife.11627.021Figure 6---figure supplement 2.Analysis of endocytic ultrastructures in sympathetic mutant fibers.(**A**) Representative electron microscopy images of sympathetic nerves exiting the SCG dissected from E16.5 WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos. Note that WT axons contain more endocytic structures (colored in red) than mutant axons. Two representative pictures are shown for each genotype. (**B**) Camera lucida of the endocytic structures shown in (**A**). (**C**) Quantification of the number of endocytic structure per area in WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* axons section, and ratio between the area of endocytic structures and the area of axons in WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* nerves section. Data are represented as mean +/- s.e.m. n = 2--3. Scale bars = 500 nm.**DOI:** [http://dx.doi.org/10.7554/eLife.11627.021](10.7554/eLife.11627.021)

To better discriminate vesicular staining in sympathetic axons, we cultured SCGs explants from WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* E16.5 embryos. In vitro, axonal extension was not statistically different in sympathetic neurons from *PLAT^CRE^::Meis1^LoxP/LoxP^* and WT embryos ([Figure 7A](#fig7){ref-type="fig"}), confirming that proximal axonal growth is not affected by *Meis1* inactivation. In these cultures, immunochemical analysis demonstrated a strong reduction in the numbers of clathrin^+^, Synaptophysin-1^+^ (Syp1) and Rab5^+^ cargoes in *Meis1*-inactivated sympathetic axons compared to WT ([Figure 6D,E](#fig6){ref-type="fig"}). To further investigate the traffic of endosomal cargoes, time-lapse imaging was performed on SCGs cultured from WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* E16.5 embryos. Overexpressing a Rab5-GFP construct in mutant neurons did not rescue the number of Rab5^+^ endosomes, suggesting that the loss of Rab5 immunoreactivity is due to a loss of endosomal structures rather than a loss of Rab5 protein expression ([Figure 6D](#fig6){ref-type="fig"}). Accordingly, analysis of E16.5 sympathetic nerves by transmission electron microscopy (TEM) showed that the number and the surface area occupied by endocytic structures per axon section were reduced in mutant nerves ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). Time-lapse analysis on SCGs explants indicates that the percentages of motile, including moving and oscillating, Rab5-GFP^+^ endosomes were dramatically reduced in mutant neurons, whereas the percentage of pausing Rab5^+^ cargoes were accordingly increased ([Figure 7B and C](#fig7){ref-type="fig"}; [Videos 1](#media1){ref-type="other"}--[4](#media4){ref-type="other"}). In addition, the velocity of both anterograde and retrograde Rab5-GFP^+^ endosomes was reduced in mutant neurons ([Figure 7D,E](#fig7){ref-type="fig"}). Altogether, these results demonstrated that in the sympathetic nervous system, part of the transcriptional program mediated by Meis1 is necessary for Rab5^+^ endocytic structures formation and traffic.10.7554/eLife.11627.022Figure 7.*Meis1* is necessary for early endosomes trafficking.(**A**) Camera lucida of TH-immunochemistry and quantification of neurites length on SCGs explants form WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos. (**B**) Individual frames and corresponding kymograph of a 2 min time lapse video showing the movement of Rab5-GFP^+^ endosomes in WT ([Video 1](#media1){ref-type="other"}) and *PLAT^CRE^::Meis1^LoxP/LoxP^* ([Video 3](#media3){ref-type="other"}) cultured SCGs explants. (**C**) Analysis of the percentage of the number of Rab5-GFP^+^ endosomes that are pausing, moving or oscillating in WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* cultured SCGs explants. (**D**) Measure of the velocity of Rab5-GFP^+^ endosomes that are moving in WT and mutant conditions. (**E**) Measure of the velocity of Rab5-GFP^+^ endosomes that are moving retrogradely and anterogradely in WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* cultured SCGs explants. Data are represented as mean +/- s.e.m; n = 3; \*\*\*p≤0.005. Scale bar = 200 µm in **A**, 20 µm in **B**. See also [Videos 1](#media1){ref-type="other"}--[4](#media4){ref-type="other"}.**DOI:** [http://dx.doi.org/10.7554/eLife.11627.022](10.7554/eLife.11627.022)Video 1.Traffic of Rab5-GFP^+^ endosomes in WT neurons.Representative videos showing 2 min acquisition of Rab5-GFP^+^ endosomes trafficking in the axons of cultured WT sympathetic neurons. See also [Figure 7](#fig7){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.11627.023](10.7554/eLife.11627.023)10.7554/eLife.11627.023Video 2.Impaired traffic of Rab5-GFP^+^ endosomes in *Meis1* inactivated neurons.Representative videos showing 2 min acquisition of Rab5-GFP^+^ endosomes trafficking in the axons of cultured *PLAT^CRE^::Meis1^LoxP/LoxP^* sympathetic neurons. See also [Figure 7](#fig7){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.11627.024](10.7554/eLife.11627.024)10.7554/eLife.11627.024Video 3.Traffic of Rab5-GFP^+^ endosomes in WT neurons.Representative videos showing 2 min acquisition of Rab5-GFP^+^ endosomes trafficking in the axons of cultured WT sympathetic neurons. See also [Figure 7](#fig7){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.11627.025](10.7554/eLife.11627.025)10.7554/eLife.11627.025Video 4.Impaired traffic of Rab5-GFP^+^ endosomes in *Meis1* inactivated neurons.Representative videos showing 2 min acquisition of Rab5-GFP^+^ endosomes trafficking in the axons of cultured *PLAT^CRE^::Meis1^LoxP/LoxP^* sympathetic neurons. See also [Figure 7](#fig7){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.11627.026](10.7554/eLife.11627.026)10.7554/eLife.11627.026

Discussion {#s3}
==========

In this work, we demonstrated that genetic inactivation of *Meis1* in rodent results in an imbalanced sympatho-vagal regulation of heart functions leading to conduction defects, chronotropic incompetence and premature SCD. In addition, we demonstrated that Meis1 acts independently of the well-studied network of transcription factors governing early specification of sympathetic neurons to orchestrate later phases of neuronal differentiation. Its inactivation results in defects of distal innervation and progressive neuronal apoptosis. Identification of Meis1 effector genes revealed a large number of genes involved in endosomal and clathrin-coated cargoes formation and fusion, as well as cytoskeletal proteins participating in their anchoring and transport. Accordingly, loss of *Meis1* function impairs Rab5^+^ endosomes formation and trafficking.

The multilevel origin in the trigger, the persistence and the termination of a variety of inherited arrhythmias such as long QT syndrome, Brugada syndrome, progressive cardiac conduction block, sinus node dysfunction, catecholaminergic polymorphic ventricular tachycardia or sudden infant death syndrome is well established ([@bib52]), and include an imbalanced autonomic regulation. For instance, studies in mice and humans have revealed the implication of Sema3a-mediated sympathetic axonal guidance and patterning in the development of ventricular tachycardia and SCD ([@bib51]; [@bib87]; [@bib39]). Here, we demonstrated that *Meis1* inactivation results at adult stages in a persistent and spontaneous bradycardia, blocks of conduction and severe sinus arrests independently of any cardiac malformation. The situation irreversibly deteriorated in conditions requiring sympathetic activation to restore cardiac homeostasis such as drug administration or the recuperation period following physical activity, thus demonstrating the complete chronotropic incompetence of these mice. In humans, such chronic heart rate abnormalities are associated with the lethal dysrhythmias observed in athletes ([@bib66]). Similarly, for infant SCD in which the autonomic regulation is compromised, severe hypoxia or anoxia during sleep lead to lethal bradycardia because autoresuscitation, also known as the Lazarus phenomenon, cannot be initiated to restore heart rate, blood pressure and breathing ([@bib119]; [@bib142]). Thus, a failure in sympathetic activation during this phase leads to unexpected and sudden death. Such an increased risk of SCD following exercise and during sleep has also been reported in dogs with inherited spontaneous cardiac arrhythmia ([@bib22]). Similar to our results, in these dogs, the sympathetic innervation is defective. A previous study on E14.5 *Meis1*^-/-^ embryos has revealed ventricular septal defect and an overriding aorta in both right and left ventricles ([@bib117]). In our study, *PLAT^CRE^::Meis1^LoxP/LoxP^* embryos did not present such gross structural defects as evidenced by histologic and echocardiographic measure of several parameters. Observation of the septum in the long and short axis and functional evaluation of the outflow did not reveal any differences between WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* mice. In particular, a defect in the septum of adult *PLAT^CRE^::Meis1^LoxP/LoxP^* mice would have resulted in dissimilar measures of systolic and diastolic performances due to hemodynamic and rigidity variations. Nevertheless, a septal defect was present when the *Meis1^LoxP/LoxP^* strain was crossed with another strain well-known to recombine in neural crest derivatives, the *Wnt1^CRE ^* strain, confirming the previously reported function of *Meis1* in cardiac neural crest ([@bib117]). This difference could be due to an earlier expression of the CRE recombinase when driven by the *Wnt1* promoter compared to the *PLAT*. Another explanation could be a lower recombination efficiency of the *PLAT^CRE^* strain specifically in the cardiac neural crest lineage. We conclude that gross morphological alterations similar to those previously reported ([@bib117]) do not contribute to the phenotype reported here.

Our results further complement the study by Mahmoud *et al*. demonstrating *Meis1* function in the regulation of neonatal cardiomyocytes mitosis especially following myocardial infarction ([@bib72]). However, cardiac functions were not affected following specific *Meis1* inactivation or overexpression in cardiomyocytes ([@bib72]). Finally, because the *Meis* family participates in cardiogenesis ([@bib117]; [@bib72]) and has been associated with SCD by independent GWA studies ([@bib93]; [@bib116]), it is tempting to speculate that *Meis1* mutations in humans would result in heart dysfunctions due to cardiac malformations and/or regeneration, sympatho-vagal deregulation of cardiac rhythmicity, or a combination of dysfunctions affecting both compartments.

The onset of Meis1 expression after the early noradrenergic specification transcription factors and noradrenergic markers together with the unaltered expression of Gata3, Phox2b, Hand2 and TH at E14.5 following *Meis1* inactivation demonstrated that Meis1 acts independently of the pathways regulating early sympathetic neurons specification. Accordingly, Phox2b expression remained unchanged at later embryonic stages and at P0 in a double *Meis1::Bax* null context. These findings were confirmed by the normal formation of the sympathetic ganglia up to E14.5 in *Meis1* mutants, whereas in *Ascl1, Phox2b, Hand2* or *Gata3* null mutants, early sympathetic neurons lose TH and DBH expression, fail to proliferate and to coalesce in a ganglion and precociously die upon arrival in the sympathetic anlage ([@bib107]).

In Drosophila, inactivation of *Homothorax (Hth*), the ortholog of *Meis1*, leads to neuronal and dendritic patterning defect in the PNS ([@bib60]; [@bib4]; [@bib7]). Hth is also required for survival of a subset of postmitotic motoneurons and rescuing them from apoptosis demonstrated that Hth shapes axons and dendrites by regulating a set of target genes independently of Hox functions ([@bib7]). However, the precise mechanism and the transcriptional targets by which Hth mediates these effects have not been elucidated. We propose that the regulation of the expression of genes involved in early endosomes formation and transport by Meis1 is a means of coordinating target-field innervation and survival. Accordingly, our identification of Meis1 effector genes highlighted numerous key genes for vesicles formation, fusion and transport, thus providing support for a coordinated action of Meis1 in retrograde dependent target-field innervation and neuronal survival.

The transcriptional program we identified by ChIP-seq is in broad agreement with ChIP-seq performed by others on other tissues ([@bib139]; [@bib92]). In a ChIP-seq performed on E11.5 trunk mouse embryos, ontology analysis of potential Meis1 target genes identified among the most enriched Meis1 bound sequences, genes involved in nervous system development, axonal guidance and synapse organization ([@bib92]). More surprisingly, comparison of our ChIP-seq results with results of a ChIP-seq conducted on a hematopoietic progenitor cell line revealed 37% of common potential targets between these two tissues ([@bib139]). Strikingly, these shared genes represent 41, 56, 75 and 50% of the genes we classified as involved in synaptic machinery, in clathrin/dynein complexes, in microtubule-associated axonal growth and in the regulation of endocytosis respectively ([Figure 6---source data 3](#SD4-data){ref-type="supplementary-material"}). From our ChIP-seq analysis, we independently confirmed that the expression of Syt1, Lnp, Adam19, Nbea and Dst mRNAs is modified. Although endosomal structures present a high diversity in their shapes and molecular compositions depending on the process they participate in, they also share a number of proteins assuming similar roles. Syt1 is an example of protein present in most, if not all, vesicular types where it acts as calcium sensor for exocytosis and endocytosis ([@bib58]; [@bib121]; [@bib104]). Syt1 serves, just like synaptophysin, as a high affinity receptor at the plasma membrane of nerves-endings for clathrin AP-2, therefore participating in clathrin coated-pit nucleation and endocytosis ([@bib143]; [@bib45]). Syt1 also promotes axonal filopodia formation and branching in fibroblasts and embryonic chick forebrain neurons in culture ([@bib36]; [@bib43]). We therefore conclude that at least part of the transcriptional program governed by Meis1 influences endocytosis and retrograde transport. In line with this, we demonstrated in E16.5 embryos, a time when retrograde transport is critical for neuronal survival and target-field innervation, that clathrin immunoreactivity is virtually absent from *Meis1* inactivated sympathetic neurons. In sympathetic neurons growing from cultured SCGs explants, the numbers of Rab5^+^, Syp1^+^ and clathrin^+^ cargoes were also reduced, and overexpressing Rab5 was unable to rescue the number of Rab5^+^ endosomes. In addition, time-lapse analysis demonstrated profound alterations in the traffic and velocity of the remaining Rab5^+^ endosomes, and TEM analysis showed that within sympathetic axons from mutant embryos the number as well as the surface area occupied by endocytic figures is reduced. We thus conclude that the transcriptional program initiated by Meis1 interferes with the retrograde transport of trophic factors as was hypothesized for Hth in Drosophila motor neurons ([@bib7]).

Because many organelles and various kind of vesicles use similar transport machinery, the loss of expression of universal components such as Syt1, Syp1, Clathrin and Rab5 raises the possibility that other mechanisms than Ngf/Ntrk1 retrograde transport are affected. Indeed, our result are consistent with a function of Meis1 interfering with the retrograde transport of several trophic factors.

In our study, we detected an increased apoptosis of *Meis1* inactivated sympathetic neurons at E14.5 that did not result in a significant variation in the volume of the SCGs, and at E16.5 concomitantly with a significant reduction in the volume of the mutant SCGs. By E18.5, the volume of the mutant SCGs was massively reduced. Whereas the increased apoptosis at E16.5 and the further dramatic decrease of SCG volume at E18.5 coincides with the period of retrograde-signal mediating target-field innervation and survival, early apoptosis at E14.5 does not. Similarly, because in *Ngf* knockout mice, the defects in distal sympathetic innervation does not affect the trachea ([@bib41]), we tentatively conclude that *Meis1* inactivation not only impairs Ngf/Ntrk1 retrograde signaling but also other retrograde signals important for survival. Among potential retrograde signaling pathways influencing sympathetic neurons survival, members of the Gdnf family of ligands and their receptors play important functions. They participate in various aspects of embryonic sympathetic development including precursors migration, proliferation, axonal growth and neurons survival ([@bib34]). Early sympathetic neurons (E12) express Ret, GFRα1, 2 and 3 ([@bib90]). Artn serves as an intermediate target derived trophic factor for sympathetic neurons ([@bib50]). In vitro, it influences the proliferation of neuroblasts from E12 to E14 and exerts a transient survival effect on newly generated neurons during this period ([@bib5]). In agreement, in *GFRα3* KO the proliferation of neuroblasts is affected ([@bib5]), but inactivation of *Artn* or *GRFα3* does not induce apoptosis at E14.5 ([@bib50]). In *Ret* mutants, SCGs are mislocated and axonal growth defects are found starting E10.5 to E13 ([@bib33]). However, no increase in Casp3 staining was found before E16.5 and apoptosis is enhanced only perinataly ([@bib33]). In *Gdnf* mutants, there is a 35% reduction in the number of SCG neurons at P0 but earlier embryonic stages have not been investigated ([@bib86]). However, in vitro, Gdnf promotes the survival of 30% of E13.5 rat sympathetic neurons ([@bib46]). Whether Gdnf can be retrogradely transported by sympathetic neurons remains controversial. Studies in neonatal and adult sympathetic indicate that Gdnf is not a retrograde survival factor ([@bib65]; [@bib130]), whereas others reported in rat embryonic neurons that application of Gdnf to the distal compartment induces axonal growth and survival via a retrograde signaling involving GFRα1 ([@bib19]). The expression of Gdnf and Artn in various intermediate and/or final target organs of sympathetic neurons during development ([@bib13]; [@bib29]; [@bib50]; [@bib84]) suggests that these factors may be retrogradely transported at least during the embryonic period. It is also possible that other yet unidentified factors use retrograde transport to mediate target-field innervation and survival. We conclude that the dramatic decrease in the number of sympathetic neurons we observed at E18.5 and the general defect in target organs innervation are likely to result from impaired retrograde signaling of more than one trophic factor. Among them, because of its well-established function in target-field innervation and survival, we focused our study on retrograde Ngf/Ntrk1 downstream signaling as a proof of impaired retrograde signaling. In addition, the molecular relation between Rab5^+^ endosomes and neurotrophins retrograde signaling including retrograde Ntrk1/Ngf signaling has been extensively documented ([@bib25], [@bib24]; [@bib136]; [@bib21]; [@bib67]; [@bib134]; [@bib94]). Indeed, downstream readout of Ngf/Ntrk1 retrograde signaling *i.e.* the nuclear expression of phosphorylated CREB ([@bib103]) and the level of Ntrk1 expression confirmed an impairment of Ngf/Ntrk1 retrograde signaling. This is supported by the decreased number of pCREB^+^ neurons at E14.5 when the first small subset of Ngf responsive sympathetic neurons are observed ([@bib18]; [@bib57]), and the decreased nuclear expression of pCREB at E16.5 when survival of most sympathetic neurons depends on retrograde Ngf/Ntrk1 signaling ([@bib41]; [@bib62]). Similarly, because in sympathetic neurons the maintenance of Ntrk1 expression depends on retrogradely transported Ngf and because Klf7 is regulated by Ngf ([@bib27]), the down regulation of Ntrk1, and possibly Klf7 we report in *Meis1* mutant is likely to be a consequence of impaired retrograde signaling of this neurotrophin. However, although the participation of Ngf/Ntrk1 retrograde signaling in the neuronal loss observed after E16.5 is supported by the loss of Ntrk1 expression and by the rescue of *Meis1* inactivated sympathetic neurons in a null *Bax* context at P0, we have no direct evidence of an Ngf dependent apoptosis. In line with this, although it was initially proposed that the survival effect of retrograde Ngf/Ntrk1 signaling was mediated through CREB activation ([@bib102]; [@bib69]), specific inactivation of CREB in sympathetic neurons protects against developmentally regulated apoptosis ([@bib91]). Thus, the decrease in pCREB expression in *Meis1* mutant cannot explain the neuronal loss.

The increased apoptosis at E14.5 remains more intriguing. It involves about 5% of TH-positive cells in the SCGs and does not result in a significant volume decrease of the mutant SCGs at this stage. In other mutant mice, apoptosis at this stage has been reported ([@bib73]; [@bib6]). For instance, Met is expressed in SCG from E12.5 embryo ([@bib73]) and blocking of HGF signaling or Met inactivation prevent early sympathetic neuroblasts differentiation into neurons from E12.5 to E14.5 without affecting their proliferation. During this period of development, HGF/Met favors the survival of sympathetic neuroblasts and in Met mutants apoptosis is increased at E14.5 ([@bib73]). In Fz3 mutants, apoptosis is increased at E13.5 and E14.5 in sympathetic neuroblasts but cannot be rescued by *Bax* elimination ([@bib6]). It is thus possible that Meis1 influences the survival of a small subset of sympathetic neuroblasts by interfering with one of the above pathways. Another explanation could be that a small subset of neurons depends on the retrograde transport of a trophic factor other than Ntrk1 at this stage. This hypothesis is consistent with the lack of induction of Syt1 expression at E14.5 whereas the induction of Ntrk1 expression is unaffected. Finally, our ChIP-seq experiment identified several potential target genes known to be involved in axonal growth and/or guidance (about 20%) as well as many other genes which function has not been yet studied. Thus, we cannot exclude that a deregulation of the expression of some of these genes is responsible for the apoptosis in this small subset of neurons. For instance, *Gdnf* was identified as a potential target gene in this search. Since the function of Gdnf on survival of early SCG neurons remains unclear, and because some studies detected Gdnf mRNA in embryonic sympathetic neurons ([@bib128]), a potential regulation of its expression by Meis1 could account for the increased apoptosis of this small subset of neurons.

To conclude, our results show that *Meis1* inactivation induces apoptosis of embryonic sympathetic neurons through different mechanisms: a severe loss of neurons occurring after E16.5 in which impaired retrograde trafficking of Ngf/Ntrk1 is a contributing factor together with other target-derived trophic factors, and a weaker apoptosis from E14.5 to E16.5 that is independent of Ngf/Ntrk1 retrograde signaling.

How *Meis1* is regulated in sympathetic neurons? In our study, we showed that *Meis1* is not regulated by Ngf. In several neuronal and non-neuronal tissues, Meis1 expression is differentially modulated by retinoic acid (RA) and bFGF. Mouse embryos treated with high doses of RA show increased levels of Meis1 ([@bib98]) and in the chick limb bud, RA induces Meis1 expression whereas bFGF reduces it ([@bib81]). During development of striatonigral projection neurons, retinoic acid and FGF are required for positioning the boundaries of Meis1-expressing cells ([@bib99]). Thus, when RARβ is inactivated, the number of Meis1 positive cells is increased and this effect can be reversed by addition of FGF2 ([@bib99]). Meis1 expression is also induced in differentiated forebrain-derived neural stem cells in the presence of bFGF ([@bib8]). In P19 and F9 carcinoma cells and in the U937 human leukemic monocyte lymphoma *cell* line, RA treatment rapidly induces Meis1 expression ([@bib37]; [@bib68]; [@bib80]). In RA-treated human carcinoma cell line NT2/D1, a treatment that induces neuronal terminal differentiation, Meis1 is also up regulated ([@bib38]). In agreement with a potential regulation of *Meis1* expression by RA during sympathetic neurons development, all RA receptors RARα, RARβ, RARγ and RXR are dynamically expressed ([@bib96]; [@bib28]).

The role of RA in neurogenesis, axonal growth and maintenance of differentiated neurons is well known and relies on complex mechanisms depending on RA receptors expression, RA concentration, cellular context and time-exposure, ([@bib17]; [@bib71]). The complexity of RA signaling is outlined by the various effects reported depending on embryonic stages and the species analyzed with sometimes conflicting results. In chick, a role of RA in sympathetic target field-innervation and neurons survival has been suggested ([@bib106]; [@bib137]; [@bib96]; [@bib101]; [@bib100]). RA induces Ntrk1 expression and regulates the onset of Ngf dependence ([@bib106]; [@bib137]; [@bib97]). In chick, the expression of the other neurotrophins receptors is not modified by RA ([@bib137]), although RA also potentiates the survival and neurite outgrowth induced by Ntf3 ([@bib97]) likely through Ntrk1 activation. At later stages, RA also reduces the survival effect of Gdnf and Neurturin of chick sympathetic neurons by preventing GFRα1, GFRα2 and Ret expression ([@bib28]).

In rodents, the scenario seems different. RA treatment of mouse and rat sympathetic neurons prevents Ntrk1 mRNA developmental induction and increases Ntrk3, Ntrk2 and Ngfr mRNA expression ([@bib56]; [@bib140]). Contrary to chick, RA enhances Gdnf and Ntf3 responsiveness of cultured rat sympathetic neurons ([@bib125]). Interestingly, RA induces the expression of several synaptic vesicles proteins including SYT1 in human neural stem cell ([@bib31]). Less is known about the function of FGFs in early sympathetic neurons. FGF8 is expressed in E14.5 mouse sympathetic neurons ([@bib122]), and FGF2 and FGFR1 are expressed in rat postmitotic sympathetic neurons ([@bib89]). bFGF induces a sympathetic neuron phenotype on PC12 cells and promotes neurite outgrowth and survival ([@bib108]). In chromaffin cells, it induces a dependence on Ngf for survival ([@bib118]). Thus, it seems that during sympathetic neurons development, RA and FGFs regulate the responsiveness of sympathetic neurons to multiple neurotrophic factors, which is in agreement with the function of Meis1 we propose. If such a regulation exists, it could be hypothesized that Meis1 is necessary to ensure the transition from local to target-derived neurotrophic signaling.

Two classes of transcription factors involved in late neuronal differentiation have been recently defined: terminal selector genes and dedicated maintenance factors ([@bib48]; [@bib47]; [@bib49]; [@bib26]; [@bib3]). Terminal selector genes group transcriptional regulators of effector genes defining a unique identity trait for a given subtype of neuron. Their removal results in the loss of many functionally unrelated terminal identity features such as neurotransmitter identity, neurotransmitter receptors, ion channels, whereas features shared by all neurons such as expression of synaptic vesicle proteins are unaffected ([@bib26]). Dedicated maintenance transcription factors include genes whose expression commences after neuron-type identity is acquired and that are not involved in initial specification ([@bib26]). Rather, they are necessary for maintenance of neuronal identity and survival. Terminal selector genes for sympathetic neurons unambiguously include *Phox2b, Gata3* and *Hand2* which the most studied function is to control the expression of TH and DBH, two key enzymes involved in the noradrenergic identity ([@bib107]). Thus, according to these definitions and from our results, *Meis1* belongs to the second class of dedicated maintenance factors. A well-studied example of such factors is the Engrailed (Eng) family. In *Eng1/2* double mutants, mesencephalic dopaminergic neurons are generated and specified normally before being progressively eliminated by apoptosis ([@bib113] , [@bib114]; [@bib2]; ; [@bib110]). In vitro, proximal axonal growth in double *Eng1/2* mutant is unaffected whereas in vivo, the projections of these neurons toward the basal telencephalon are missing. Interestingly, in Eng1/Eng2 double mutants, neuronal apoptosis is preceded by a loss of α-synuclein expression ([@bib113]), a vesicular protein able to modulate clathrin-dependent endocytosis, vesicle trafficking and recycling ([@bib63]; [@bib10]; [@bib88]; [@bib14]; [@bib54]; [@bib135]). Thus, the neuronal phenotypes we report following *Meis1* inactivation strikingly resemble the phenotypes reported for Eng mutation in mesencephalic dopaminergic neurons. Whether the regulation of generic traits for all neurons is a common feature of this class of dedicated maintenance factors remain to be explored.

Finally, it has been proposed that disruption of transcriptional maintenance programs is a key to increased susceptibility to late onset neurodegenerative disease ([@bib26]). Since Meis1 is expressed by numerous post-mitotic neurons ([@bib127]), it is likely that the transcriptional program initiated by Meis1 that we reported in sympathetic neurons will be generalized to other class of CNS neurons.

Materials and methods {#s4}
=====================

Animals {#s4-1}
-------

Procedures involving animals and their care were conducted according to European Parliament Directive 2010/63/EU and the 22 September 2010 Council on the protection of animals, and were approved by the institutional animal research committee (Departmental Directorate of protecting populations and animal health (ethics for animal welfare and environmental protection, N° A 34- 485/CEEA-LR-12074) and by our Ethics committee for animal experiments, Languedoc Roussillon, N° 34--376, February the 17^th^ of 2009). *Meis1^LoxP/LoxP^, PLAT^CRE^*, and *Bax^-/-^* mice were generated as previously described ([@bib55]; [@bib23]; [@bib95]; [@bib132]). Primers used to genotype the different strains were: *Meis1* sense 5'-CCA AAG TAG CCA CCA ATA TCA TGA-3'; *Meis1* antisense 5'-AGC GTC ACT TGG AAA AGC AAT GAT-3'; *Bax* sense 5'-GAG CTG ATC AGA ACC ATC ATG-3'; *Bax* antisense 5'-GTT GAC CAG AGT GGC GTA GG-3'; *Neo* antisense 5'-CCG CTT CCA TTG CTC AGC GG-3'; *CRE* sense 5'-TGC CAG GAT CAG GGT TAA AG-3'; *CRE* antisense 5'-GCT TGC ATG ATC TCC GGT AT-3'. Mice were kept in an animal facility and gestational stages were determined according to the date of the vaginal plug. For ECG recordings, sex-matched 12-weeks old transgenic and littermates mice (n = 8 in each group) were used.

Antibodies {#s4-2}
----------

The antibodies used are: mouse anti-Meis1 (Millipore, 05--779, 1/100 for immunoblotting, Germany), goat anti-Meis1 (Santa Cruz, sc-10599, 1/100 for immunochemistry, Dallas, Texas, USA), sheep anti-TH (Thermo Scientific, PA1-4679, 1/2000, Waltham, MA, USA), rabbit anti-PGP9.5 (Millipore, AB1761, 1/500, Germany), goat anti-Nrp-1 (R&D Systems, AF566, 1/250, Minneapolis, USA), rabbit anti-Synaptophysin (Cell Signaling Technology, 5461, 1/250, Danvers, MA, USA), rabbit anti-Phox2b (kindly provided by JF Brunet, 1/250, or Abcam ab183741, 1/250, UK), goat anti-c-Ret (R&D Systems, AF482, 1/20000, Minneapolis, USA), rabbit anti-Ntrk1 (Millipore, 06--574, 1/250, Germany), rabbit anti-Cleaved Caspase-3 (Cell Signaling Technology, 9661, 1/250, Danvers, MA, USA), rabbit anti-Clathrin Heavy Chain 1 (Thermo Scientific, PA5-17347, 1/200, Waltham, MA, USA), Phospho-CREB (Cell Signaling, 87G3, 1/200, Germany), Rab5 (Abcam, ab18211, 1/200, UK), Sox2 (Santa Cruz, sc-17320, 1/250, Dallas, Texas, USA).

Immunochemistry {#s4-3}
---------------

Immunofluorescent staining on frozen sections were performed as previously described ([@bib79]). For Phox2b and Meis1 immunostaining, an epitope retrieval step was carried out by immersion of the sections for 15 min at 68° in sodium citrate buffer (10 mM Sodium Citrate, 0.05% Tween 20 \[pH 6\]).

To analyze sympathetic neurons proliferation, intraperitoneal injections of 0.7 mg of EdU (5-ethynyl-2´-deoxyuridine; A10044, Life Technologies) were performed on E16 pregnant mice 3 hr before sacrifice. Embryos were harvested and tissues sections were prepared as previously described. Incorporated EdU was revealed using the Click-iTEdUAlexa Fluor488 Imaging Kit (Life Technologies, C10337, Waltham, MA, USA), according to the manufacturer's instructions. Wide field microscopy (Leica DMRB, Germany) was only used for ISH images and confocal microscopy (Leica SP5-SMD, Germany) for immunochemistry except for the [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} where an epifluorescent microscope (Leica DMRB, Germany) was used. Confocal images are presented as single stacks except for images in [Figure 3B](#fig3){ref-type="fig"} that is displayed as maximal projections.

Hematoxylin-Eosin staining {#s4-4}
--------------------------

Air dried frozen sections were washed in water then stained with hematoxylin for 1 min at room temperature and washed extensively with water. Slides were then dehydrated in a PBS/alcohol (70%) solution and stained with eosin for 30 sec at room temperature. After serial wash in water, sections were finally dehydrated in PBS solutions with increasing alcohol concentration (50%, 75%, 95%, and 100%), mounted and observed with a microscope (Leica DMRB, Germany).

Transmission electron microscopy (TEM) {#s4-5}
--------------------------------------

For electron microscopy, SCGs were dissected with their exiting nerve and immersed in a solution of 2.5% glutaraldehyde in PHEM buffer (1X, pH 7.4) overnight at 4°C. They were then washed in PHEM buffer and post-fixed in a 0.5% osmic acid + 0.8% *Potassium ferrocyanide solution* for 2 hr at room temperature in the dark. After two washes with PHEM buffer, samples were dehydrated with solutions of increasing ethanol concentration (30--100%). Samples were embedded in EmBed 812 using an Automated Microwave Tissue Processor for Electronic Microscopy, Leica EM AMW. Thin sections (70 nm; Leica-Reichert Ultracut E) were collected at different levels of each block. These sections were counterstained with uranyl acetate and lead citrate and observed using a Hitachi 7100 transmission electron microscope in the Centre de Ressources en Imagerie Cellulaire de Montpellier (France).

Probes for in situ hybridization (ISH) {#s4-6}
--------------------------------------

RNA probes were generated from cDNA sequences that were PCR-amplified from reverse-transcribed total RNA isolated from whole E13 mouse embryos. Amplified fragments were cloned into the pGEM-T easy vector using the TA cloning kit (Promega, Madison, Wisconsin, USA) and confirmed by sequencing. Ntrk1, Ntrk2, Ntrk3, Ret, DBH, Gata3, Hand2, Sox10 probes were published elsewhere ([@bib59]; [@bib129]; [@bib12]). Meis1 probe was a generous gift from Mark Featherstone ([@bib111]). Digoxigenin- (DIG) and fluorescein- labeled RNA probes were synthesized using the DIG- or Fluorescein labeling kit (Roche, Switzerland), respectively, according to the manufacturer's instructions. Simple and double ISH were conducted as previously described ([@bib79]). The primers used for cloning ISH probes are indicated in the following table.

ForwardReverseMeis25'-ATGGCGCAAAGGTACGATGAGCT-3'5'- TTACATATAGTGCCACTGCCCATC-3'Meis35'-ATGGCCCGGAGGTATGATG-3'5'-CTATAGGTAATGCCACTCTCCT-3'Ngfr5'-AGC GGCATCTCTGTGGAC-3'5'-GGAGAAGGGAGGGGTTGA-3'Adam195'-GTTTTACCGCTC CCTGAACA-3'5'-GGAAGATTC AGT GCCAGAGC-3'Nbea5'-GAGCAGAGTTTTGCCCACTC-3'5'-CATAGCATGGCACAACAACC-3'Dst5'-AGTGAACAGAAACCCGTTGG-3'5'-TCAGCATGTTGTCCAGCTTC-3'Syt15'-CGATGCTGAAACTGGACTGA-3'5'-AAGGGCATAGGGGCTTTCTA-3'Lnp5'-CCCAGCGCTCTATCTGTAGG-3'5'-GTTGAGCTTGAGCCTTCCAC-3'Klf75'-ACAAAACAAAACAAAAGGGCCACTG-3'5'-CAGGTGCAAAGCCCTTTAAG-3'

In situ hybridization (ISH) {#s4-7}
---------------------------

RNA probes were generated from cDNA sequences that were PCR-amplified from reverse-transcribed total RNA isolated from whole E13 mouse embryos using primers listed in expanded view. Amplified fragments were cloned into the pGEM®-T easy vector using the TA cloning kit (Promega) and confirmed by sequencing. Ntrk1, Ntrk2, Ntrk3, Ret, DBH, Gata3, Hand2, Sox10 probes were published elsewhere ([@bib59]; [@bib129]; [@bib12]). Meis1 probe was a generous gift from Mark Featherstone ([@bib111]). Digoxigenin- (DIG) and fluorescein- labeled RNA probes were synthesized using the DIG- or Fluorescein labeling kit (Roche, Switzerland), respectively, according to the manufacturer's instructions. Simple and double ISH were conducted as previously described ([@bib79]).

Cell culture and live imaging {#s4-8}
-----------------------------

SCG explants were dissected from E16 mouse embryos and seeded in FluoroDish dishes (World Precision Instruments, Sarasota, FL, USA) coated with poly-L-ornithine (0.5 mg/ml) and laminin (5 μg/ml). Explants were cultivated in neurobasal medium (Life Technologies, Waltham, MA, USA) containing B27 serum (2%, Life Technologies, Waltham, MA, USA), Glutamine (2 mM, Life Technologies, Waltham, MA, USA), Glutamic acid (25 µM, Life Technologies, Waltham, MA, USA), Penicillin-Streptomycin (200 U/ml, Life Technologies, Waltham, MA, USA) and Ngf (10 ng/ml, Life technologies, MNAC-25, Waltham, MA, USA). After 24 hr in culture, explants were electroporated with a Rab5-GFP plasmid ([@bib105]) (500 ng/µl) in PBS 1X using a BTX *Electro Square Porator ECM 830* (2 times 3 pulses of 200 V/cm, separated by intervals of 15 ms). The movements of Rab5-GFP^+^ vesicles were recorded 24h after electroporation on a confocal microscope (Leica SP5-SMD, Germany) at 37°C in a *humidified* atmosphere containing 5% CO~2~ for 2 min for each acquisition.

Western blot {#s4-9}
------------

Cells were lysed in Laemmli buffer containing 62.5 mM Tris-HCl, pH 6.8, 25% glycerol, 2% SDS, 0.01% Bromophenol Blue and 5% β-mercaptoethanol. All protein samples were separated on SDS-PAGE, transferred on nitrocellulose membrane (Proteigene, 10401197, France), and probed with primary antibodies. HRP-conjugated goat anti-mouse secondary antibody (Jackson ImmunoResearch, 115-035-174, 1/500, Baltimore, PA, USA) was revealed by chemo-luminescence using the Pierce ECL Plus Western Blotting Substrate (Thermo Scientific, 32132, Waltham, MA, USA). Signals were detected using autoradiographic films (Sigma Aldrich, Z363022-50EA, Saint-Louis, Missouri, USA) or light sensitive camera (BioRad, ChemiDo XRS + System, Hercules, California, USA).

Quantifications {#s4-10}
---------------

For the calculation of innervation density, the total TH/PGP9.5 fibers areas were measured with ImageJ software ([@bib109]), using the "\'analyze particles\' option after adjusting the threshold with the max entropy method. The total neurites length was measured with ImageJ software on multiple random fields for each experimental condition. The calculation of SCGs volumes, immunochemistry intensities and ISH intensities were measured with the ImageJ software using the \'measure\'option. The intensity of the background signal was subtracted to each measure. All quantifications were realized on at least 3 sections per embryos and at least 3 different embryos per genotype. For SCG volumes calculation, the area of the SCG present in each section within a series were measured, increased by the number of series and the thickness of the sections, and finally added. Statistical comparisons were performed by a Student's T-test. Values and errors bars indicate respectively the mean and the s.e.m.

In live imaging experiment, time-lapse acquisition was performed on 6 to 8 different neurons from 3 different WT and *PLAT^CRE^::Meis1^LoxP/LoxP^* SCG explants.

In TEM experiments, the number of endocytic structures per axons and the area ratio (area of endocytic structures per axons/area of axons) were measured on at least 5 pictures randomly taken in each samples. Samples were obtained from 3 WT and 2 *PLAT^CRE^::Meis1^LoxP/LoxP^* sympathetic nerves.

ECG recording and HRV (Heart Rate Variability) analysis {#s4-11}
-------------------------------------------------------

Electrocardiogram (ECG) monitoring (2000 Hz) were performed by telemetry system using PhysioTel®ETAF20 teletransmitter (DSI, USA) and IOX software (EMKA Technologies, France). Continuous 24 hr ECGs were analyzed with ECG-auto software (EMKA Technologies, France), in respect of circadian light/dark cycles (12 hr/12 hr). The mean RR interval and the mean PR, QRS, QTc durations were calculated. The QT interval was defined as the time between the first deviation from an isoelectric PR interval until the return of the ventricular repolarization to the isoelectric TP baseline from lead II ECGs. The QT correction was performed with the adapted Bazett's formula of Mitchell ([@bib83]). Arrhythmia were detected and counted by hand, according to the Lambeth conventions guidelines ([@bib138]). ECG analyses were also performed after pharmacological i.p. injection of isoproterenol hydrochloride (β-adrenoreceptor agonist, 1 mg.kg^-1^, NaCl 0.9%) or carbamoylcholine chloride (non-selective cholinergic agonist, 0.5 mg.kg^-1^, NaCl 0.9%). The chronotropic response was studied during exercise on treadmill (10 min of baseline recording, following by 5 min at 90 m.min^-1^, 2 min at 120 m.min^-1^, 2 min at 140 m.min^-1^, 2 min at 160 m.min^-1^ and 6 min of recuperation).

Heart rhythm is triggered by electrical activity which is continuously adapted to metabolic needs. This beat-to-beat regulation is largely modulated by the autonomic nervous system (ANS). ANS controls the heart rhythm by modifying the automatic sinus activity through a complex interplay of the orthosympathetic and parasympathetic (or vagal) systems. The orthosympathetic system increases beat delivery via the rostral ventrolateral medulla whereas the vagal system slows it via the ambiguus and vagal dorsal motor nuclei. Time- and frequency domain indices of HRV are the standard parameters to evaluate ANS activity as well in clinics as in fundamental research. Time-domain analysis measures changes in R--R intervals between successive normal (sinusal) cardiac cycles over time. All HRV indices in the time domain are based on descriptive statistical calculations. In frequency domain, power spectral analysis is performed by Fast Fourier Transform, a non-parametric method characterized by discrete peaks for the several frequency components ([@bib1]; [@bib75]; [@bib124]). The FFT thus converts time information into frequency information by decomposing the periodic oscillations of sinus heart rate into harmonics characterized by specific frequencies and amplitudes. The power spectrum of HRV in mice is similar those derived from humans showing two principal components: the LF and HF frequencies ([@bib40]; [@bib126]). In this study, HRV was evaluated by power spectra analysis (ms^2^) using the fast Fourier transformation (segment length of 2048 beats, linear interpolation with resampling to a 20-Hz interbeat time series and Hamming windowing). The cut-off frequency ranges for the low frequency (LF: 0.15--1.5 Hz) and high frequency powers (HF: 1.5--5 Hz) were chosen according to those used in the literature ([@bib126]). As in humans, the low frequency reflects a complex interaction between sympathetic and parasympathetic ways that modulates heart rate in mice ([@bib40]; [@bib126]). Therefore, we assessed total variability with the standard deviation of all normal RR intervals (SDNN) and, the vagal activity from HF ([@bib40]) in the frequency domain and from the square root of the mean square successive differences between successive normal intervals (RMSSD) in the time domain. The cardiac sympathetic and baroreflex activities were assessed from LF ([@bib32]; [@bib76]; [@bib40]; [@bib126]) in the frequency domain. As in previous studies, we used the LF to HF ratio (LF/HF) to quantify the sympathovagal balance ([@bib11]; [@bib123]). In mice the sympathetic nervous system is one major factor that controls basal heart rate ([@bib78]; [@bib131]).

Chromatin immuno-precipitation (ChIP) {#s4-12}
-------------------------------------

Chromatin immune-precipitation has been performed with the Low Cell ChiP Kit (Diagenode, kch-maglow-A16, Belgium) according to the manufacturer's instructions with minors modifications. Eighteen to 25 SCGs from E16 C57Bl6 embryos were dissected in PBS with protease inhibitors (Sigma-Aldrich, P2714-1BTL, Saint-Louis, Missouri, USA). Fixation was done by adding PBS/PFA 1% for 10 min under agitation at room temperature and then stopped in 0.125 µM glycine for 5 min under agitation at room temperature. After three washings in PBS1X, chromatin was isolated and sheared by sonication (16 cycles composed by 30' pulses following by 30' without pulses on a BIORUPTOR STANDARD) to obtain a smear between 250 and 1000 bp. Immunoprecipitation was performed overnight at 4°C with 10 µL of beads previously coupled with 10 µL of Meis1/2/3 antibody (Millipore, 05--779, Germany) or IgG1 isotype control antibody (Sigma-Aldrich, M5284). The Meis1/2/3 antibody has been previously validated for ChIP experiment or co-immunoprecipitation ([@bib112]; [@bib93]). The DNA was then purified using the iPure kit (Diagenode, C03010012, Belgium) according to the manufacturer's instructions. Sequencing was realized by MGX platform (Montpellier Genomix, Montpellier) using a HiSeq 2000 sequencing system (Illumina, San Diego, California, USA). Data were analyzed using the CA-SAVA software for alignment and the MACS software for statistical analyses. Signals were annotated by the name of the genes flanking the 20 kb to the precipitated sequence. Bibliographical search was realized using PubMed. The data discussed in this publication have been deposited in NCBI\'s Gene Expression Omnibus ([@bib30]) and are accessible through GEO Series accession number GSE54144 (<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE54144>).

Echocardiography {#s4-13}
----------------

Doppler echocardiography was performed using a high resolution ultrasound system (Vevo 2100; VisualSonics, Toronto, Canada) equipped with a 40-MHz transducer. Mice were anesthetized with 1.5% isofluranein 100% oxygen to reach comparable heart rate and placed on a heating table in a supine position. Body temperature was monitored through a rectal thermometer to be maintained at 36--38°C and ECG was recorded all along the echocardiographic procedure with limb electrodes. Ejection fraction (EF%) and fractional shortening (FS%) were calculated from the left ventricular diameters on M-mode measurements at the level of papillary muscles in a parasternal short-axis two dimensional view. To better consider left ventricular morphology, EF was also calculated from a B-mode parasternal long axis view (EF% B-mode) by tracing endocardial end-diastolic and end-systolic borders to estimate left ventricular volumes, and the endocardial fractional area change (FAC%) on a parasternal short-axis view at papillary muscle level was similarly measured. Mitral flow was recorded by a pulsed-wave Doppler sampling at the tips of the mitral valves level from the apical four-chamber view. Peak early (E) and late atrial contraction (A) mitral inflow waves velocities were measured and the ratio E/A was calculated. Pulsed-wave Doppler of the ascending aortic blood flow was recorded permitting measurements of the velocity time integral (AoVTI). All measurements were quantified and averaged for three cardiac cycles.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your work entitled \"Loss of *Meis1* prevents sympathetic neurons target-field innervation and increases susceptibility to sudden cardiac death\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by David Ginty (Reviewing Editor) and K VijayRaghavan (Senior Editor).

The reviewers have discussed the reviews with one another and the Reviewing editor has drafted this decision to help you prepare a revised submission.

Summary:

In this manuscript, Bouilloux et al., propose a role for the transcription factor, *Meis1*, in neurotrophin-dependent development of sympathetic neurons, likely via regulating the vesicular machinery. There are several strengths of this study; ([@bib1]) the phenotypes in the *Meis1* mutant mice, specifically the defects in autonomic physiology and the developmental defects in the sympathetic nervous system are striking and convincingly demonstrated. Specifically, the autonomic physiology defects in sympathetic regulation of cardiac functions are interesting and highlight the consequences of perturbations in peripheral innervation during development on target organ function later in life. ([@bib2]) As noted by the authors, much of the work on transcriptional regulation of sympathetic nervous system development has been restricted to early stages of neuronal specification and differentiation. Thus, the identification of a transcription factor that influences later aspects of sympathetic neuronal survival and connectivity is a significant aspect of this study. The study does a nice job demonstrating physiological relevance with the heart analysis and the modeling of sudden cardiac death syndrome. Overall this is a rigorous and fairly comprehensive analysis. ([@bib3]) In general, the physiological and histochemical analyses have been done rigorously and the data are of high quality. The reviewers appreciate the data showing that cell death in *Meis1* sympathetic ganglia is prevented by removing *Bax*, similar to that noted in *NGF;Bax* double knockout mice. This supports the authors' conclusions that it is post-mitotic sympathetic neurons that rely on target-derived neurotrophins that are being eliminated in the absence of *Meis1*, and not neuronal precursors or glial cells.

Essential revisions:

1\) There is a serious concern about the mechanistic data and the interpretations. Specifically, whether the developmental phenotypes are due to a failure in retrograde NGF signaling is not clear. Concerns include: i) innervation of some targets (e.g. trachea) is strongly reduced in *HtPACRE/Meis1^LoxP/LoxP^*mice but not in *NGF^-/-^* mice (Glebova and Ginty, 2004) and, ii) the early cell death at E14.5 ([Figure 3D](#fig3){ref-type="fig"}) cannot be explained by reduced NGF/TrkA signaling. Naturally occurring cell death in sympathetic ganglia starts at E16-17 (Coughlin and Collins, 1985). In mice that lack NGF neuron loss can be detected by E17.5 (Crowley at al., 1994; Francis and Collins, 1999), iii) although pCREB may indicate NGF signaling it should be noted that sympathetic neuron development is not dependent on cell-autonomous CREB/pCREB (Parlato et al, 2007). Thus, while a deficit in retrograde NGF signaling may be a contributing factor it is unclear whether it accounts for the phenotype. There is also the technical concern that the immunostaining data for clathrin, Rab5 and synaptotagmin ([Figure 6](#fig6){ref-type="fig"}) are not convincing enough to make the claim that \"clathrin-coated vesicles are virtually absent from *Meis1* inactivated neurons\" (Discussion section). Thus, the reviewers agree that your study requires direct analysis of TrkA trafficking (TrkA internalization and axonal transport) and more rigorous imaging of endocytic/synaptic organelles (instead of just Rab5 transport). Also, even if deficits in NGF trafficking are observed, statements in the Abstract and Discussion that disrupted retrograde NGF signaling accounts for the sympathetic neuron survival defects should be softened.

2\) The human tissue plasminogen activator (HtPA) Cre-mouse targets all neural crest derivatives including heart outflow tract (Pietri et al, 2003). As the *Meis1*-knockout has defects in the heart outflow tract (Stankunas et al., 2008) it may be expected that the development of cardiac neural crest derivatives is also affected in the *HtPACRE/Meis1^LoxP/LoxP^*mice. The authors argue that heart morphology and function are normal in *HtPACRE/Meis1^LoxP/LoxP^*mice (e.g. from [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). In the Discussion (first paragraph) the authors refer to Mahmoud et al. (2013), which showed that a conditional *Meis1* knockout in cardiomyocytes does not affect heart morphology and physiology. But HtPACRE is acting earlier and on different cell types than aMHCCRE. This is a potential complication and some of the conclusions would be in question if effects on heart development rather than sympathetic neuron development cannot be excluded in *HtPACRE/Meis1^LoxP/LoxP^* mice. The reviewers think that a more detailed explanation of the heart defects in the *Meis1* mutant mice is warranted, in the Discussion.

3\) The authors should provide data on the innervation density in adult hearts, preferably of mice that show the described physiological phenotype to exclude the possibility that the surviving neurons have sprouted between E16.5 and adult stages.

10.7554/eLife.11627.030

Author response

*Essential revisions:*

*1) There is a serious concern about the mechanistic data and the interpretations. Specifically, whether the developmental phenotypes are due to a failure in retrograde NGF signaling is not clear. Concerns include: i) innervation of some targets (e.g. trachea) is strongly reduced in HtPACRE/Meis1^LoxP/LoxP^ mice but not in NGF^-/-^ mice (Glebova and Ginty, 2004) and, ii) the early cell death at E14.5 ([Figure 3D](#fig3){ref-type="fig"}) cannot be explained by reduced NGF/TrkA signaling. Naturally occurring cell death in sympathetic ganglia starts at E16-17 (Coughlin and Collins, 1985). In mice that lack NGF neuron loss can be detected by E17.5 (Crowley at al., 1994; Francis and Collins, 1999), iii) although pCREB may indicate NGF signaling it should be noted that sympathetic neuron development is not dependent on cell-autonomous CREB/pCREB (Parlato et al, 2007). Thus, while a deficit in retrograde NGF signaling may be a contributing factor it is unclear whether it accounts for the phenotype. There is also the technical concern that the immunostaining data for clathrin, Rab5 and synaptotagmin ([Figure 6](#fig6){ref-type="fig"}) are not convincing enough to make the claim that \"clathrin-coated vesicles are virtually absent from Meis1 inactivated neurons\" (Discussion section). Thus, the reviewers agree that your study requires direct analysis of TrkA trafficking (TrkA internalization and axonal transport) and more rigorous imaging of endocytic/synaptic organelles (instead of just Rab5 transport). Also, even if deficits in NGF trafficking are observed, statements in the Abstract and Discussion that disrupted retrograde NGF signaling accounts for the sympathetic neuron survival defects should be softened.*

We fully understand the concern of the reviewers. It was not our intention in the first place to leave the reader with the impression that impaired retrograde NGF/TrkA signaling was responsible alone for all the defects we report in *Meis1* mutant. Several changes have been made throughout the manuscript in the summary, the presentation of the results and Discussion to emphasize this essential point and we hope that the revised version has now cleared up this ambiguity (Abstract; subsection "Loss of target-field innervation signaling pathways in *Meis1*-inactivated sympathetic neurons", last paragraph; Discussion, seventh and eighth paragraphs). We now emphasize that the early apoptosis in *Meis1* mutant (E14.5) is not compatible with the period of target-derived NGF dependent apoptosis, and that whereas the late apoptosis (E16.5-18.5) likely involves NGF/TrkA retrograde signaling, the default in the innervation of the trachea indicates that other signaling pathways must be affected. In the Results section, we now describe the progressive loss of neurons as occurring in two phases (subsection "*Meis1* deficient sympathetic neurons progressively die by apoptosis", last paragraph, Discussion, eighth paragraph), with one clearly independent of NGF/TrkA retrograde signaling, and a second one during which the neuronal loss is accentuated and to which NGF/TrkA retrograde signaling contributes. In the Discussion, we now discuss which additional pathways could be involved (paragraphs eight to ten). We also cite the manuscript of Parlato et al. (Parlatoet al., 2007) to indicate that the loss of pCREB expression cannot account for apoptosis, and we emphasize that pCREB staining was only used as readout of retrograde NGF/TrkA signaling (subsection "Loss of target-field innervation signaling pathways in *Meis1*-inactivated sympathetic neurons"; Discussion, eighth paragraph).

We also agree that the decreased immunostaining for clathrin, Rab5 and synaptotagmin ([Figure 6](#fig6){ref-type="fig"}) are not convincing enough to make the claim that \"clathrin-coated vesicles are virtually absent from *Meis1* inactivated neurons\". This sentence has been changed to "clathrin immunoreactivity is virtually absent from *Meis1* inactivated neurons\" (Discussion). In addition, we bring a new set of Transmission Electron Microscopy (TEM) analysis of E16.5 sympathetic nerves. In these analyses, we observed a decrease in the surface area occupied by endocytic figures, as well as the number of these endocytic figures per surface area of axons. These TEM results are now presented in [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}. Six to seven embryonic sympathetic nerves from different embryos in each group were dissected and prepared for TEM. However, because of the time needed for dissection combined with a critical fixation time, we were satisfied with the quality of only 2 to 3 of these preparations in each group. For this reason, and because according to experts, TEM is difficult to quantify, these results are presented in a supplementary figure and were not statistically analyzed. Altogether, our results on clathrin, syp1 and Rab5 immunoreactivity along with Rab5-GFP overexpression and TEM analysis indicate that not only immunoreactivity is decreased but also the number and size of endocytic figures.

During the time of revision, we carried out several attempts to directly analyze TrkA trafficking in our explant culture of SCG neurons. Two different TrkA-GFP constructs from different sources were used. Unfortunately and for unknown reasons, we were not able to detect TrkA-GFP following electroporation even in WT cultures. A reason might be the much larger size of the TrkA-GFP plasmid construct compared to the Rab5-GFP construct. Thus, in our conditions, these TrkA-GFP plasmid constructs were not efficiently transfected. These different trials brought our colony so low that several months now would be needed to properly set-up the experimental conditions. We feel very sorry that we cannot bring a positive answer on this special point. Nevertheless, as mentioned by the reviewer, even with a direct visualization of TrkA trafficking, statements in the abstract and discussion should have been softened which was done throughout the entire manuscript.

*2) The human tissue plasminogen activator (HtPA) Cre-mouse targets all neural crest derivatives including heart outflow tract (Pietri et al, 2003). As the Meis1-knockout has defects in the heart outflow tract (Stankunas et al., 2008) it may be expected that the development of cardiac neural crest derivatives is also affected in the HtPACRE/Meis1^LoxP/LoxP^ mice. The authors argue that heart morphology and function are normal in HtPACRE/Meis1^LoxP/LoxP^ mice (e.g. from [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). In the Discussion (first paragraph) the authors refer to Mahmoud et al. (2013), which showed that a conditional Meis1 knockout in cardiomyocytes does not affect heart morphology and physiology. But HtPACRE is acting earlier and on different cell types than aMHCCRE. This is a potential complication and some of the conclusions would be in question if effects on heart development rather than sympathetic neuron development cannot be excluded in HtPACRE/Meis1^LoxP/LoxP^ mice. The reviewers think that a more detailed explanation of the heart defects in the Meis1 mutant mice is warranted, in the Discussion.*

We thank the reviewers for pointing out this point. In view of the published works on cardiac septum defect in *Meis1* full knockout (Stankunaset al., 2008) and the well-known participation of neural crest cells in the formation of the cardiac septum, we understand the concern of the reviewers whether or not structural cardiac defects are present in the *HtPA^Cre^/Meis1^LoxP/LoxP^*strain and contribute to the reported phenotype. To solve this issue, we now added some new data and extended the discussion of our echocardiographic and ECG analysis.

Histological analysis of *HtPA^Cre^/Meis1^LoxP/LoxP^*E14.5 embryos and control littermates revealed no septal defect in any of the analyzed embryos. To better understand the difference in septal defect between full *Meis1* KO and *HtPA^Cre^/Meis1^LoxP/LoxP^* mice, we generated *Wnt1^CRE^/ Meis1^LoxP/LoxP^* animals. The *Wnt1^CRE^* also induces recombination in neural crest cells and their derivatives (to our experience, earlier and broader) and has previously been used to inactivate genes in cardiac neural crest derivatives. Because the *Wnt1^CRE^* transgene is inserted near the *Meis1* locus on chromosome 11, the extremely low rate of recombination prevented a large study and only one *Wnt1^CRE^/Meis1^LoxP/LoxP^* mutant could be generated out of 120 embryos collected (although Mendelian ratios were consistent). In this embryo, there was a septal defect similar to the one described in other *Meis1* KO strains. This difference means that either the recombination efficiency is low in neural crest cells contributing to the cardiac lineage when using the *HtPA^CRE^* line or that *Meis1* is important earlier during cardiac neural crest cells delamination because the Wnt1^CRE^ strain induces recombination earlier than the *HtPA^CR^*^E^ strain. These results are now presented ([Figure 1---figure supplement 1E](#fig1s1){ref-type="fig"}), described in the Results section (subsection "*Meis1* inactivation in the PNS compromises the sympatho-vagal regulation of cardiac function", second paragraph), and discussed in the Discussion section (second paragraph). Accordingly, whereas the *Wnt1^CRE^*strain has been used widely to study cardiac neural crest cells, we were unable to find any report using the *HtPA^CRE^* strain to study this lineage although it has been used in several reports studying the peripheral nervous system including enteric, sympathetic and sensory neurons (Pietriet al., 2003, Pietriet al., 2004, Breauet al., 2006, Haoet al., 2006). These results strongly vindicate our choice of the *HtPA^CRE^* strain to study *Meis1* function in the peripheral sympathetic nervous system and the consequences of its inactivation on autonomic regulation of cardiac functions. We conclude that the cardiac phenotype we report in the present study is not complicated by the morphological heart defects previously reported by Stankunas et al.

This conclusion is strengthened by the morphologic, functional and hemodynamics parameters measured in our transthoracic-echocardiography experiments. According to the guidelines recommendations for left ventricle function assessment (Langet al., 2015), measurements performed in the parasternal long axis and short axis views allow characterizing contractile function and morphology. Both views attest to the absence of wall structure defects in the *Meis1* mutant, including the septal wall observed in the long axis view. The ejection fraction (EF), which is used as the conventional contractile function index, was not different from WT mice. Measuring systolic performance tracing all along endocardial end-diastolic and end-systolic borders also excludes a possible left ventricular abnormal regional remodeling (EF B-mode and FAC; [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). Finally, heart diastolic performance was assessed by measuring left ventricle filling waves ([Figure 1---figure supplement 2D; E](#fig1s2){ref-type="fig"}/A ratio in [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}) in standard 4 cavities view. A septum closure defect would result in different filling values in WT and mutant mice because of hemodynamic and rigidity consequences. To conclude, in our *HtPA^CRE^/Meis1^LoxP/LoxP^*mice, basal septal wall observation during 4 cavities view and evaluation of aortic and ventricular hemodynamic outflows measured functionally by echocardiography did not revealed any impairment.

In addition, ECG analyses during baseline did *not show* alterations reflecting structural abnormalities, and ECG analyses during pharmacological challenge with compounds that mimic autonomic neurotransmitters showed that only the regulation of cardiac function by the sympathetic nervous system is compromised whereas the ability of cardiomyocyte to activate adrenergic and cholinergic pathways is preserved.

The lack of differences between WT and mutant mice in all these parameters strongly indicates that the gross morphological defects reported by Stankunas et al. do not contribute to the phenotype we report here. We now discuss this point in detail (Discussion, second paragraph) and completed our manuscript with a more detailed description of echographic parameters in the Results section (subsection "*Meis1* inactivation in the PNS compromises the sympatho-vagal regulation of cardiac function", third paragraph).

*3) The authors should provide data on the innervation density in adult hearts, preferably of mice that show the described physiological phenotype to exclude the possibility that the surviving neurons have sprouted between E16.5 and adult stages.*

As mentioned by the reviewers in this comment, we understand the relevance of investigating sympathetic sprouting. A recent study indicates that sympathoectomy in neonatal rat by 6-OHDA injection leads to a moderate sympathetic sprouting between the 7^th^ day and the 8^th^ week post injection (Kreipke and Birren, 2015). To answer this point, we analyzed the innervation density in the heart of adult WT and *HtPA^CRE^/Meis1^LoxP/Lox^*^P^ mice. The whole hearts were embedded and cryo-sectioned at 14µm thickness. Every eighth section (representing 20-38 sections in total) underwent immunochemistry for TH and was fully scanned using a Nanozoomer using the 40X objective. The total length of all TH-positive fibers was measured using the ImageJ software in each section and normalized by the area of the section. Data represent the average innervation density per section. Unfortunately, due to the low level of our colony only 2 hearts for each phenotype were available in the schedule for revision. Nevertheless the results show that the innervation density in the heart of *HtPA^CRE^/Meis1^LoxP/LoxP^* mice was not increased at adult stages compared to E16.5 embryos ([Figure 4B and C](#fig4){ref-type="fig"}) and P0 mice ([Figure 4D](#fig4){ref-type="fig"}). These new results are now presented in the [Figure 1---figure supplement 1F and G](#fig1s1){ref-type="fig"}. Because sympathetic sprouting following myocardial injury involves among other factors NGF signaling (Kimuraet al., 2012), this result raises the possibility again that impaired retrograde NGF in *Meis1* mutant prevents sympathetic sprouting. Another possible explanation is that *Meis1* itself is involved in sympathetic sprouting. In line with the second hypothesis, the transcription factor Stat3, a well-characterized player in axonal regeneration for peripheral neurons was also identified in our ChiP-seq experiment as a putative *Meis1* transcriptional target. Although not investigated in our study, we believe that these hypotheses are highly relevant in the field of peripheral nerves regeneration and sympathetic cardiac remodeling following injury. They would certainly deserve further attention and thorough investigations. We did not investigate these hypotheses, as we believe that it is beyond the scope of the present work.

[^1]: These authors contributed equally to this work.
